UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________

 


FORM 10-Q
_____________


(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017March 31, 2021 or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to ___________________

Commission File Number 1-36117

inTEST Corporation
(Exact Name of Registrant as Specified in its Charter)

 

Delaware
(State or other jurisdiction of incorporation or organization)

22-2370659
(I.R.S. Employer Identification Number)

 

804 East Gate Drive, Suite 200
Mt. Laurel, New Jersey 08054
(Address of principal executive offices, including zip code)

(856) 505-8800
(Registrant's Telephone Number, including Area Code)
_________________

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
Common Stock, par value $0.01 per share

Trading Symbol

INTT

Name of Each Exchange on Which Registered
NYSE American

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES ☒      NO ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SS 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
YES ☒      NO 


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or aan emerging growth company. See the definitions of "large accelerated filer," "accelerated filer"filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ___

Accelerated filer   ___☐ 

Non-accelerated filer     ___ (Do not check if a smaller reporting company)☒ 

Smaller reporting company  X  ☒ 

Emerging growth company   ___☐ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ___☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ☐      NO 


Number of shares of Common Stock, $.01$0.01 par value, outstanding as of the close of business on October 31, 2017:

10,413,058April 30, 2021:   10,747,131

 

 

 

 

inTEST CORPORATION

INDEX

 

Page

PART I.

FINANCIAL INFORMATION

 
   

Item 1.

Financial Statements

 

 

Consolidated Balance Sheets as of September 30, 2017March 31, 2021 (Unaudited) and December 31, 20162020

1

Unaudited Consolidated Statements of Operations for the three months ended March 31, 2021 and nine months ended September 30, 2017 and 20162020

2

Unaudited Consolidated Statements of Comprehensive Earnings (Loss) for the three months ended March 31, 2021 and nine months ended September 30, 2017 and 20162020

3

Unaudited Consolidated StatementStatements of Stockholders' Equity for the ninethree months ended September 30, 2017March 31, 2021 and 2020

4

Unaudited Consolidated Statements of Cash Flows for the ninethree months ended September 30, 2017March 31, 2021 and 20162020

5

Notes to Consolidated Financial Statements

6-186

 

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

19-27

20

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

27

 

Item 4.

Controls and Procedures

27

 

PART II.

OTHER INFORMATION

 

 

Item 1.

Legal Proceedings

28

 

Item 1A.

Risk Factors

28

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

28

 

Item 3.

Defaults Upon Senior Securities

28

 

Item 4.

Mine Safety Disclosures

28

 

Item 5.

Other Information

28

 

Item 6.

Exhibits

29

28

 

SignaturesSIGNATURES

30

29

 

 

 

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

inTEST CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)

 

 

March 31,

  

December 31,

 
 

September 30,

  

December 31,

  

2021

  

2020

 
 

2017

  

2016

  

(Unaudited)

     

ASSETS

 (Unaudited)             

Current assets:

                

Cash and cash equivalents

 $11,499  $28,611  $10,195  $10,277 

Trade accounts receivable, net of allowance for doubtful accounts of $146 and $146, respectively

  10,225   5,377 

Trade accounts receivable, net of allowance for doubtful accounts of $212

  13,487   8,435 

Inventories

  6,033   3,676   8,212   7,476 

Prepaid expenses and other current assets

  714   342   562   776 

Total current assets

  28,471   38,006   32,456   26,964 

Property and equipment:

                

Machinery and equipment

  4,993   4,383   5,401   5,356 

Leasehold improvements

  730   603   2,901   2,636 

Gross property and equipment

  5,723   4,986   8,302   7,992 

Less: accumulated depreciation

  (4,179)  (4,042)  (5,764

)

  (5,642

)

Net property and equipment

  1,544   944   2,538   2,350 

Deferred tax assets

  -   1,110 

Right-of-use assets, net

  6,099   6,387 

Goodwill

  13,738   1,706   13,738   13,738 

Intangible assets, net

  16,259   875   12,117   12,421 

Restricted certificates of deposit

  175   175   140   140 

Other assets

  27   28   38   30 

Total assets

 $60,214  $42,844  $67,126  $62,030 
                

LIABILITIES AND STOCKHOLDERS' EQUITY

                

Current liabilities:

                

Accounts payable

 $2,363  $1,368  $3,655  $2,424 

Accrued wages and benefits

  2,218   1,588   2,044   1,944 

Accrued rent

  530   572 

Accrued professional fees

  682   419   515   776 

Customer deposits and deferred revenue

  1,191   396 

Accrued sales commissions

  476   287   703   472 

Customer deposits and deferred revenue

  1,111   74 

Current portion of operating lease liabilities

  1,160   1,215 

Domestic and foreign income taxes payable

  1,087   575   1,157   825 

Current portion of contingent consideration liability

  -   - 

Other current liabilities

  400   173   746   804 

Total current liabilities

  8,867   5,056   11,171   8,856 

Operating lease liabilities, net of current portion

  5,753   6,050 

Deferred tax liabilities

  4,010   -   1,913   1,922 

Contingent consideration liability, net of current portion

  3,574   - 

Other liabilities

  440   450 

Total liabilities

  16,451   5,056   19,277   17,278 
                

Commitments and Contingencies

                
        

Stockholders' equity:

                

Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding

  -   -   -   - 

Common stock, $0.01 par value; 20,000,000 shares authorized; 10,444,135 and 10,394,018 shares issued, respectively

  104   104 

Addtional paid-in capital

  25,808   25,578 

Common stock, $0.01 par value; 20,000,000 shares authorized; 10,743,408 and 10,562,200 shares issued, respectively

  108   106 

Additional paid-in capital

  27,835   26,851 

Retained earnings

  17,212   11,671   19,322   17,110 

Accumulated other comprehensive earnings

  843   639   788   889 

Treasury stock, at cost; 33,077 and 33,077 shares, respectively

  (204)  (204)

Treasury stock, at cost; 33,077 shares

  (204

)

  (204

)

Total stockholders' equity

  43,763   37,788   47,849   44,752 

Total liabilities and stockholders' equity

 $60,214  $42,844  $67,126  $62,030 

 

See accompanying Notes to Consolidated Financial Statements.

 

- 1 --1-

 

 

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)

 

 

Three Months Ended September 30,

  

Nine Months Ended September 30,

  

Three Months Ended

March 31,

 
 

2017

  

2016

  

2017

  

2016

  

2021

  

2020

 
                        

Net revenues

 $17,352  $10,823  $47,420  $29,955  $19,556  $11,230 

Cost of revenues

  8,556   5,246   22,475   14,982   10,035   6,363 

Gross margin

  8,796   5,577   24,945   14,973   9,521   4,867 
        

Operating expenses:

                        

Selling expense

  2,322   1,394   5,861   4,200   2,403   2,052 

Engineering and product development expense

  1,139   905   3,056   2,878   1,322   1,292 

General and administrative expense

  3,143   1,574   8,423   5,364   3,161   2,876 

Adjustment to contingent consideration liability

  (549)  0   (549)  0 

Restructuring and other charges

  55   8 

Total operating expenses

  6,941   6,228 
                        

Total operating expenses

  6,055   3,873   16,791   12,442 

Operating income

  2,741   1,704   8,154   2,531 

Other income

  100   17   195   63 

Earnings before income tax expense

  2,841   1,721   8,349   2,594 

Income tax expense

  823   631   2,808   937 

Net earnings

 $2,018  $1,090  $5,541  $1,657 

Operating income (loss)

  2,580   (1,361

)

Other expense

  (2

)

  (32

)

                        

Net earnings per common share - basic

 $0.20  $0.11  $0.54  $0.16 

Earnings (loss) before income tax expense (benefit)

  2,578   (1,393

)

Income tax expense (benefit)

  366   (250

)

                        

Net earnings (loss)

 $2,212  $(1,143

)

        

Net earnings (loss) per common share - basic

 $0.21  $(0.11

)

                        

Weighted average common shares outstanding - basic

  10,288,325   10,295,447   10,276,682   10,327,095   10,329,449   10,220,853 
                        

Net earnings per common share - diluted

 $0.19  $0.11  $0.54  $0.16 

Net earnings (loss) per common share - diluted

 $0.21  $(0.11

)

                        

Weighted average common shares and common share equivalents outstanding - diluted

  10,351,009   10,318,715   10,327,080   10,344,747   10,525,826   10,220,853 

 

See accompanying Notes to Consolidated Financial Statements.

 

- 2 --2-

 

 

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In thousands)
(Unaudited)

  

Three Months Ended September 30,

  

Nine Months Ended September 30,

 
  

2017

  

2016

  

2017

  

2016

 
                 

Net earnings

 $2,018  $1,090  $5,541  $1,657 
                 

Foreign currency translation adjustments

  21   (6)  204   35 
                 

Comprehensive earnings

 $2,039  $1,084  $5,745  $1,692 

 See accompanying Notes to Consolidated Financial Statements.

 

- 3 -
  

Three Months Ended
March 31,

 
  

2021

  

2020

 
         

Net earnings (loss)

 $2,212  $(1,143

)

         

Foreign currency translation adjustments

  (101

)

  (38

)

         

Comprehensive earnings (loss)

 $2,111  $(1,181

)


inTEST CORPORATION
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

(In thousands, except share data)
(Unaudited)

  ��               

Accumulated

         
          

Additional

      

Other

      

Total

 
  

Common Stock

  

paid-in

  

Retained

  

Comprehensive

  

Treasury

  

Stockholders'

 
  

Shares

  

Amount

  

capital

  

Earnings

  

Earnings

  

Stock

  

Equity

 
                             

Balance, January 1, 2017

  10,394,018  $104  $25,578  $11,671  $639  $(204) $37,788 
                             

Net earnings

  -   -   -   5,541   -   -   5,541 

Other comprehensive income

  -   -   -   -   204   -   204 

Amortization of deferred compensation related to stock-based awards

  -   -   292   -   -   -   292 

Issuance of unvested shares of restricted stock

  64,000   -   -   -   -   -   - 

Repurchase and retirement of common stock

  (13,883)  -   (62)              (62)
                             

Balance, September 30, 2017

  10,444,135  $104  $25,808  $17,212  $843  $(204) $43,763 

 

See accompanying Notes to Consolidated Financial Statements.

 

- 4 --3-

 

 

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWSSTOCKHOLDERS' EQUITY
(In thousands)thousands, except share data)
(Unaudited)

 

  

Nine Months Ended September 30,

 
  

2017

  

2016

 

CASH FLOWS FROM OPERATING ACTIVITIES

        

Net earnings

 $5,541  $1,657 

Adjustments to reconcile net earnings to net cash provided by operating activities:

        

Depreciation and amortization

  1,317   451 

Adjustment to contingent consideration liability

  (549)  - 

Provision for excess and obsolete inventory

  161   184 

Foreign exchange gain

  (130)  (7)

Amortization of deferred compensation related to stock-based awards

  292   222 

(Gain) loss on sale of property and equipment

  (4)  3 

Proceeds from sale of demonstration equipment, net of gain

  53   128 

Deferred income tax expense (benefit)

  (225)  141 

Changes in assets and liabilities:

        

Trade accounts receivable

  (1,060)  (2,252)

Inventories

  (581)  (57)

Prepaid expenses and other current assets

  (164)  183 

Restricted certificates of deposit

  -   125 

Other assets

  1   - 

Accounts payable

  (426)  343 

Accrued wages and benefits

  (18)  47 

Accrued rent

  (42)  (100)

Accrued professional fees

  177   64 

Accrued sales commissions

  83   74 

Customer deposits and deferred revenue

  302   (74)

Domestic and foreign income taxes payable

  472   523 

Other current liabilities

  (12)  86 
         

Net cash provided by operating activities

  5,188   1,741 
         

CASH FLOWS FROM INVESTING ACTIVITIES

        

Acquisition of business, net of cash acqured

  (21,962)  - 

Purchase of property and equipment

  (435)  (282)

Proceeds from sale of property and equipment

  35   - 
         

Net cash used in investing activities

  (22,362)  (282)
         

CASH FLOWS FROM FINANCING ACTIVITIES

        

Repurchases of common stock

  (62)  (841)
         

Net cash used in financing activities

  (62)  (841)
         

Effects of exchange rates on cash

  124   17 
         

Net cash provided by (used in) all activities

  (17,112)  635 

Cash and cash equivalents at beginning of period

  28,611   25,710 

Cash and cash equivalents at end of period

 $11,499  $26,345 
         

Cash payments for:

        

Domestic and foreign income taxes

 $2,555  $25 
         

Details of acquisition:

        

Fair value of assets acquired, net of cash

 $22,652     

Liabilities assumed

  (8,599)    

Goodwill resulting from acquisition

  12,032     

Contingent consideration

  (4,123)    

Net cash paid for acquisition

 $21,962     
  

Three Months Ended March 31, 2021

 
                             
                  

Accumulated

         
          

Additional

      

Other

      

Total

 
  

Common Stock

  

Paid-in

  

Retained

  

Comprehensive

  

Treasury

  

Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Earnings

  

Earnings

  

Stock

  

Equity

 
                             

Balance, January 1, 2021

  10,562,200  $106  $26,851  $17,110  $889  $(204

)

 $44,752 
                             

Net earnings

  -   -   -   2,212   -   -   2,212 

Other comprehensive loss

  -   -   -   -   (101

)

  -   (101

)

Amortization of deferred compensation related to stock-based awards

  -   -   269   -   -   -   269 

Issuance of unvested shares of restricted stock

  81,468   1   (1

)

  -   -       - 

Stock options exercised

  99,740   1   716   -   -   -   717 
                             

Balance, March 31, 2021

  10,743,408  $108  $27,835  $19,322  $788  $(204

)

 $47,849 

  

Three Months Ended March 31, 2020

 
                             
                  

Accumulated

         
          

Additional

      

Other

      

Total

 
  

Common Stock

  

Paid-in

  

Retained

  

Comprehensive

  

Treasury

  

Stockholders'

 
  

Shares

  

Amount

  

Capital

  

Earnings

  

Earnings

  

Stock

  

Equity

 
                             

Balance, January 1, 2020

  10,413,982  $104  $26,256  $18,005  $673  $(204

)

 $44,834 
                             

Net loss

  -   -   -   (1,143

)

  -   -   (1,143

)

Other comprehensive loss

  -   -   -   -   (38

)

  -   (38

)

Amortization of deferred compensation related to stock-based awards

  -   -   187   -   -   -   187 

Issuance of unvested shares of restricted stock

  58,160   1   (1

)

  -   -   -   - 

Forfeiture of unvested shares of restricted stock

  (8,315

)

  -   -   -   -   -   - 

Repurchase and retirement of common stock

  (13,767

)

  -   (74

)

  -   -   -   (74

)

                             

Balance, March 31, 2020

  10,450,060  $105  $26,368  $16,862  $635  $(204

)

 $43,766 

 

See accompanying Notes to Consolidated Financial Statements.

 

- 5 --4-

inTEST CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

  

Three Months Ended
March 31,

 
  

2021

  

2020

 

CASH FLOWS FROM OPERATING ACTIVITIES

        

Net earnings (loss)

 $2,212  $(1,143

)

Adjustments to reconcile net earnings (loss) to net cash used in operating activities:

        

Depreciation and amortization

  740   791 

Provision for excess and obsolete inventory

  39   171 

Foreign exchange loss

  8   38 

Amortization of deferred compensation related to stock-based awards

  269   187 

Loss on disposal of property and equipment

  22   - 

Proceeds from sale of demonstration equipment, net of gain

  7   - 

Deferred income tax benefit

  (9

)

  (93

)

Changes in assets and liabilities:

        

Trade accounts receivable

  (5,082

)

  1,188 

Inventories

  (783

)

  (714

)

Prepaid expenses and other current assets

  212   117 

Other assets

  (8

)

  (4

)

Accounts payable

  1,235   316 

Accrued wages and benefits

  103   (543

)

Accrued professional fees

  (261

)

  (105

)

Customer deposits and deferred revenue

  799   152 

Accrued sales commissions

  232   78 

Operating lease liabilities

  (343

)

  (323

)

Domestic and foreign income taxes payable

  335   (207

)

Other current liabilities

  (57

)

  (25

)

Other liabilities

  (7

)

  - 

Net cash used in operating activities

  (337

)

  (119

)

         

CASH FLOWS FROM INVESTING ACTIVITIES

        

Purchase of property and equipment

  (388

)

  (80

)

Net cash used in investing activities

  (388

)

  (80

)

         

CASH FLOWS FROM FINANCING ACTIVITIES

        

Proceeds from stock options exercised

  717   - 

Repurchases of common stock

  -   (74

)

Net cash provided by (used in) financing activities

  717   (74

)

         

Effects of exchange rates on cash

  (74

)

  (21

)

         

Net cash used in all activities

  (82

)

  (294

)

Cash and cash equivalents at beginning of period

  10,277   7,612 

Cash and cash equivalents at end of period

 $10,195  $7,318 
         

Cash payments for:

        

Domestic and foreign income taxes

 $41  $50 

See accompanying Notes to Consolidated Financial Statements.

-5-

 

 

inTEST CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(In thousands, except share and per share data)

 

(1)

NATURE OF OPERATIONS


We are an independent designer, manufacturera global supplier of innovative test and marketer of thermal management productsprocess solutions for use in manufacturing and semiconductor automatic test equipment (“ATE”) interface solutions. Our products are used by semiconductor manufacturers to perform development, qualifying and final testing of integrated circuits (“ICs”) and wafers, and for other electronic test across a wide range of industries including the automotive, defense/aerospace, energy, industrial and telecommunications markets. We also offer induction heating products for joining and forming metals in a variety of industrial markets including automotive, defense/aerospace, machinery, wire & fasteners,industrial, medical, semiconductor food & beverage, and packaging.telecommunications. We manage our business as two operating segments which are also our reportable segments and reporting units: Thermal Products ("Thermal") and Electromechanical Solutions ("EMS"). Our Thermal segment designs, manufactures and sells our thermal test and thermal process products while our EMS segment designs, manufactures and sells our semiconductor test products. We manufacture our products in the U.S. Marketing and support activities are conducted worldwide from our facilities in the U.S., Germany, Singapore, the Netherlands and the U.K. The consolidated entity is comprised of inTEST Corporation and our wholly-owned subsidiaries.

During 2016, we reorganized

Our EMS segment sells its products to semiconductor manufacturers and third-party test and assembly houses (end user sales) and to automated test equipment (“ATE”) manufacturers (original equipment manufacturer (“OEM”) sales), who ultimately resell our business from three product segments,equipment with theirs to both semiconductor manufacturers and third-party test and assembly houses. These sales all fall within the ATE sector of the broader semiconductor market. Our Thermal Products, Mechanical Products and Electrical Products, into two product segments, Thermal Products ("Thermal") and Electromechanical Semiconductor Products ("EMS"). Certain operational changes undertakensegment sells its products to many of these same types of customers; however, it also sells to customers in the first quarterwafer processing sector within the broader semiconductor market and to customers in a variety of 2016 in connection with this reorganization are discussed further in Note 3other markets outside the semiconductor market, including the automotive, defense/aerospace, industrial (including consumer products packaging, fiber optics and other sectors within the broader industrial market), medical and telecommunications markets.

Both of our operating segments have multiple products that we design, manufacture and market to our customers. Due to a number of factors, our products have varying levels of gross margin. The mix of products we sell in any period is ultimately determined by our customers' needs. Therefore, the mix of products sold in any given period can change significantly from the prior period. As a result, our consolidated financial statements includedgross margin can be significantly impacted in our Annual Report on Form 10-K forany given period by a change in the year ended December 31, 2016 filed with the Securities and Exchange Commission on March 27, 2017 (the "2016 Form 10-K"). Accordingly, effective January 1, 2017, we have two reportable segments, which are also our reporting units. Prior period information has been reclassified to be comparablemix of products sold in that period.

We refer to the presentation for 2017.

On May 24, 2017, we completedbroader semiconductor market, including the acquisition of Ambrell Corporation ("Ambrell").more specialized ATE and wafer processing sectors within that market, as the “Semi Market.” All other markets are designated as “Multimarket.” The acquisition was completed by acquiring all ofSemi Market, which is the outstanding capital stock of Ambrell. Ambrell is a manufacturer of precision induction heating systems which are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials, in order to transform raw materials into finished parts. The Ambrell acquisition complements our current thermal technologies and broadens our diverse customer base, allowing expansion within many non-ATE related markets, such as consumer product packaging, fiber-optics, automotive and other markets. Ambrell's operations are included in our Thermal segment. Ambrell manufactures its products in the U.S. and conducts marketing and support activities from its facilities in the U.S., the Netherlands and the U.K. This acquisition is discussed further in Note 3.

The ATEprincipal market in which we operate, is characterized by rapid technological change, competitive pricing pressures and cyclical as well as seasonal market patterns. This market is subject to significant economic downturns at various times.

Our financial results are affected by a wide variety of factors, including, but not limited to, general economic conditions worldwide and in the markets in which we operate, economic conditions specific to the ATE marketSemi Market and the other markets we serve, our ability to safeguard patented technology and intellectual property in a rapidly evolving market, downward pricing pressures from customers, and our reliance on a relatively few number of customers for a significant portion of our sales. In addition, we are exposed to the risk of obsolescence of our inventory depending on the mix of future business and technological changes within the markets that we serve. We also continue to implement an acquisitionPart of our strategy for growth includes potential acquisitions that may cause us to incur substantial expense in reviewingthe review and evaluatingevaluation of potential transactions. We may or may not be successful in locating suitable businesses to acquire.acquire or in closing acquisitions of businesses we pursue. In addition, we may not be able to successfully integrate any business we do acquire with our existing business and we may not be able to operate the acquired business profitably. As a result of these or other factors, we may experience significant period-to-period fluctuations in our future operating results.

 

COVID-19 Pandemic

Demand from all of the markets we serve was significantly affected by COVID-19 during the first half of 2020. The impact of COVID-19 on demand from the Semi Market was intensified during the first half of 2020 because our business operations were also being negatively affected by a global downturn in the Semi Market at that time. The Semi Market, from which approximately half of our orders and net revenues are derived, entered a cyclical downturn in the beginning of 2019. During the first quarter of 2020, before the spread of COVID-19, we had started to see indications that the downturn was coming to an end. These indications included increased quoting activity and order levels for the first quarter of 2020 compared to the fourth quarter of 2019. However, we believe COVID-19 delayed the recovery in the Semi Market as the increase in activity leveled off during late March 2020. Although we saw slightly increased order rates from our customers in the Semi Market during the second and third quarters of 2020, it was not until the fourth quarter of 2020 that we saw a significant increase in our orders from the Semi Market, which we believe indicates that we have now entered the next cyclical upturn. During the fourth quarter of 2020, our orders from the Semi Market increased 53% sequentially and were 141% higher than in the fourth quarter of 2019, the low point of the prior cyclical downturn for the products that we sell. This trend in our orders from the Semi Market continued in the first quarter of 2021 with a further 54% sequential increase from the level in the fourth quarter of 2020. We believe the level of increase in our orders and net revenues from the Semi Market during the fourth quarter of 2020 and the first quarter of 2021 reflects a combination of increased demand in the market resulting from the interruption of the normal recovery in the Semi Market cycle caused by the onset of COVID-19 in the first half of 2020, as well as increased demand for semiconductors, generally. We believe this increase in demand is being driven both by changing technology as well as increased use of technology across all aspects of daily life, such as in devices that facilitate remote work and education, smart technology used in homes and businesses, the increase in the number of integrated circuits used in the automotive industry and changes occurring in the telecommunications and mobility markets.

-6-

As of the date of this filing, all of our operations continue to be deemed “critical and essential business operations” under the various governmental COVID-19 mandates, which has allowed us to continue to operate our business with certain modifications. These modifications include a significant number of our employees working remotely. Such employees have been provided with the tools and technology necessary to do so. Additionally, we have implemented workplace safeguards designed to protect the health and well-being of our employees. Employees who remain in our facilities are following World Health Organization (“WHO”) and Centers for Disease Control and Prevention (“CDC”) recommended safety practices, as well as state and local directives. We have had occasions where one or more employees have contracted COVID-19 and entered our facilities while infected. To date, we have managed these occurrences with minimal disruption to our business while protecting other employees, but there can be no assurances that we can avoid similar occurrences in the future or, that in such cases, we can avoid significant disruption of our operations.

The aftermarket service and support that we provide to our customers has been, and we expect may continue to be, adversely impacted by COVID-19. Specifically, the travel restrictions that remain in place, coupled with limitations on visitors into customer facilities, have resulted in the reduction or suspension of in-person service and support activities. The net revenues associated with these aftermarket service and support activities typically range from 8% to 10% of our consolidated net revenues. Although these net revenues returned to a more typical range during the second half of 2020, they declined again in the first quarter of 2021. If the spread of COVID-19 or variations of the virus worsen, these revenues may continue to be reduced in future periods.

While the negative impact of COVID-19 on our business was reduced significantly in the second half of 2020 and the first quarter of 2021, the spread of the virus or variants of the virus could worsen and one or more of our significant customers or suppliers could be impacted, or significant additional governmental regulations and restrictions could be imposed, thus negatively impacting our business in the future. As a result of our current level of working capital as well as the availability of our revolving credit facility, which is discussed in Note 9, we currently expect to have sufficient liquidity to operate our business throughout 2021. Our revolving credit facility, which had no outstanding balance, was set to mature on April 9, 2021. As discussed in Note 14, we modified this facility on April 10, 2021 and extended it as modified through April 9, 2024.

(2)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Use of Estimates

The accompanying consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated upon consolidation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"(“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain of our accounts, including inventories, long-lived assets, goodwill, identifiable intangibles contingent consideration liabilities and deferred tax assets and liabilities including related valuation allowances, are particularly impacted by estimates.


 

In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the financial position, results of operations, and changes in cash flows for the interim periods presented. Certain footnote information has been condensed or omitted from these consolidated financial statements. Therefore, these consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in our 2016 Form 10-K.
10-K for the year ended December 31, 2020 (“2020 Form 10-K”) filed on March 23, 2021 with the Securities and Exchange Commission.

 

- 6 -
-7-

 

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(2)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Reclassification


Certain prior period amounts have been reclassified to be comparable with the current period's presentation.

Subsequent Events

We have made an assessment of our operations and determined that there were no material subsequent events requiring adjustment to, or disclosure in, our consolidated financial statements for the three months ended March 31, 2021 other than those described in Note 14.

Business Combinations

Acquired businesses are accounted for using the purchase method of accounting, which requires that the purchase price be allocated to the net assets acquired at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Fair values of intangible assets are estimated by valuation models prepared by our management and third partythird-party advisors. The assets purchased and liabilities assumed have been reflected in our consolidated balance sheets, and the results are included in the consolidated statements of operations and consolidated statements of cash flows from the date of acquisition. Any change in the fair value of acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, will be recognized within general and administrative expensein the consolidated statement of operations in the period of the estimated fair value change. Acquisition-related transaction costs, including legal and accounting fees and other external costs directly related to the acquisition, are recognized separately from the acquisition and expensed as incurred in general and administrative expense in the consolidated statements of operations.

Fair Value MeasurementsRestructuring and Other Charges

The fair values of our financial instruments reflect the amounts that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price).

The carrying amounts of our financial instruments of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their short maturities.

We carry our contingent consideration liability at fair value.

In accordance with the three-tierguidance in Accounting Standards Codification (“ASC”) Topic 420 (Exit or Disposal Cost Obligations), we recognize a liability for restructuring costs at fair value hierarchy, weonly when the liability is incurred. Workforce-related charges are accrued when it is determined that a liability has been incurred, which is generally after individuals have been notified of their termination dates and expected severance benefits. Depending on the fair valuetiming of the termination dates, these charges may be recognized upon notification or ratably over the remaining required service period of the employees. Plans to consolidate excess facilities may result in lease termination fees and impairment charges related to our right-of-use (“ROU”) assets that are associated with the leases for these facilities. Other long-lived assets that may be impaired as a result of restructuring consist of property and equipment, goodwill and intangible assets. Asset impairment charges included in restructuring and other charges are based on an estimate of the amounts and timing of future cash flows related to the expected future remaining use and ultimate sale or disposal of the asset, and, in the case of our contingent consideration liability using an option-based income approach with a Monte Carlo simulation model. The income approach uses Level 3, or unobservable inputs, as defined under the accounting guidance for fair value measurements. See Notes 3 and 4 for more information regarding our contingent consideration liability.

Inventories

Inventories are valued at cost on a first-in, first-out basis, not in excess of market value. Cash flows from the sale of inventories are recorded in operating cash flows. On a quarterly basis, we review our inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. These criteria identify material that has not been used in a work order during the prior twelve months and the quantity of material on hand that is greater than the average annual usage of that material over the prior three years. In certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product introductions andROU assets, would include expected future use ofsublease rental income, if applicable. These estimates are derived using the inventory. The excessguidance in ASC Topic 842 (Leases), ASC Topic 360 (Property, Plant and obsolete inventory charges we record establish a new cost basis for the related inventories. We incurred excessEquipment) and obsolete inventory charges of $161ASC Topic 350 (Intangibles - Goodwill and $184 for the nine months ended September 30, 2017 and 2016, respectively.

Other).

Goodwill, Intangible and Long-Lived Assets

We account for goodwill and intangible assets in accordance with Accounting Standards Codification ("ASC")ASC Topic 350 (Intangibles - Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment annually in the fourth quarter on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired. Goodwill is considered to be impaired if the fair value of a reporting unit is less than its carrying amount. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. If, as a result of our qualitative assessment, we determine thisthat it is more-likely-than-not that the case,fair value of the reporting unit is greater than its carrying amount, a quantitative goodwill impairment test is not required. However, if, as a result of our qualitative assessment, we determine it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, or, if we choose not to perform a qualitative assessment, we are required to perform a two-stepquantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized.

The two-step test is discussed below. If we determine that it is more-likely-than-not that the fair value of the reporting unit is greater than its carrying amounts, the two-stepquantitative goodwill impairment test is not required.

- 7 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(2)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


If we determine it is more-likely-than-not thatcompares the fair value of a reporting unit is less thanwith its carrying amount, as a result of our qualitative assessment, we will perform a quantitative two-step goodwill impairment test. In the Step I test,including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is computed and compared with its book value.considered not impaired. If the book valuecarrying amount of a reporting unit exceeds its fair value, a Step II test is performed in which the implied fair value of goodwill is compared with the carrying amount of goodwill. If the carrying amount of goodwill exceeds the implied fair value, an impairment loss is recordedwill be recognized in an amount equal to that excess.excess, limited to the total amount of goodwill allocated to that reporting unit. The two-step goodwill impairment assessment is based upon a combination of the income approach, which estimates the fair value of our reporting units based upon a discounted cash flow approach, and the market approach which estimates the fair value of our reporting units based upon comparable market multiples.approach. This fair value is then reconciled to our market capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units requires management to make significant estimates and assumptions, including the selection of appropriate peer group companies, control premiums, discount rate,rates, terminal growth rates, forecasts of revenue and expense growth rates, income tax rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting unit or the amount of the goodwill impairment charge.

-8-

Indefinite-lived intangible assets are assessed for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the option to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required. Otherwise,required; otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

Long-lived assets, which consist of finite-lived intangible assets, and property and equipment and ROU assets, are assessed for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best estimates using appropriate assumptions and projections at that time.

Revenue Recognition

We recognize revenue in accordance with the guidance in ASC Topic 606 (Revenue from Contracts with Customers). We recognize revenue for the sale of products or services when our performance obligations under the terms of a contract with a customer are satisfied and control of the product or service has been transferred to the customer. Generally, this occurs when we ship a product or perform a service. In certain cases, recognition of revenue is deferred until the product is received by the customer or at some other point in the future when we have determined that we have satisfied our performance obligations under the contract. Our contracts with customers may include a combination of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. In addition to the sale of products and services, we also lease certain of our equipment to customers under short-term lease agreements. We recognize revenue from equipment leases on a straight-line basis over the lease term. 

Revenue is recorded in an amount that reflects the consideration we expect to receive in exchange for those products or services. We do not have any material variable consideration arrangements, or any material payment terms with our customers other than standard payment terms which generally range from net 30 to net 90 days. We generally do not provide a right of return to our customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities.

Nature of Products and Services

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We sell thermal management products including ThermoStreams, ThermoChambers and process chillers, which we sell under our Temptronic, Sigma and Thermonics product lines, and Ambrell Corporation’s (“Ambrell”) precision induction heating systems, including EKOHEAT and EASYHEAT products. We sell semiconductor ATE interface solutions which include manipulators, docking hardware and electrical interface products. We provide post-warranty service for the equipment we sell. We sell semiconductor ATE interface solutions and certain thermal management products to the Semi Market. We also sell our thermal management products to various other markets including the automotive, defense/aerospace, industrial, medical and telecommunications markets.

We lease certain of our equipment under short-term leasing agreements with original lease terms of six months or less. Our lease agreements do not contain purchase options.

Types of Contracts with Customers

Our contracts with customers are generally structured as individual purchase orders which specify the exact products or services being sold or equipment being leased along with the selling price, service fee or monthly lease amount for each individual item on the purchase order. Payment terms and any other customer-specific acceptance criteria are also specified on the purchase order. We generally do not have any customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test substantially all products manufactured as part of our quality assurance process to determine that they comply with specifications prior to shipment to a customer.

-9-

Contract Balances

We record accounts receivable at the time of invoicing. Accounts receivable, net of the allowance for doubtful accounts, is included in current assets on our balance sheet. To the extent that we do not recognize revenue at the same time as we invoice, we record a liability for deferred revenue. In certain instances, we also receive customer deposits in advance of invoicing and recording of accounts receivable. Deferred revenue and customer deposits are included in current liabilities on our consolidated balance sheets.

The allowance for doubtful accounts reflects our best estimate of probable losses inherent in the accounts receivable balance. We determine the allowance based on known troubled accounts, if any, historical experience, and other currently available evidence.

Costs to Obtain a Contract with a Customer

The only costs we incur associated with obtaining contracts with customers are sales commissions that we pay to our internal sales personnel or third-party sales representatives. These costs are calculated based on set percentages of the selling price of each product or service sold. Commissions are considered earned by our internal sales personnel at the time we recognize revenue for a particular transaction. Commissions are considered earned by third-party sales representatives at the time that revenue is recognized for a particular transaction. We record commission expense in our consolidated statements of operations at the time the commission is earned. Commissions earned but not yet paid are included in current liabilities on our balance sheets.

Product Warranties

In connection with the sale of our products, we generally provide standard one- or two-year product warranties which are detailed in our terms and conditions and communicated to our customers. Our standard warranties are not offered for sale separately from our products; therefore, there is not a separate performance obligation related to our standard warranties. We record estimated warranty expense for our standard warranties at the time of sale based upon historical claims experience. We offer customers an option to separately purchase an extended warranty on certain products. In the case of extended warranties, we recognize revenue in the amount of the sale price for the extended warranty on a straight-line basis over the extended warranty period. We record costs incurred to provide service under an extended warranty at the time the service is provided. Warranty expense is included in selling expense in our consolidated statements of operations. 

Refer to Notes 5 and 13 for further information about our revenue from contracts with customers.

Inventories

Inventories are valued at cost on a first-in, first-out basis, not in excess of market value. Cash flows from the sale of inventories are recorded in operating cash flows. On a quarterly basis, we review our inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. Our criteria identify excess material as the quantity of material on hand that is greater than the average annual usage of that material over the prior three years. Effective January 1, 2021, our criteria identify obsolete material as material that has not been used in a work order during the prior twenty-four months. Prior to January 1, 2021, these criteria identified obsolete material as material that had not been used in a work order during the prior twelve months. In certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product introductions and expected future use of the inventory. The excess and obsolete inventory charges we record establish a new cost basis for the related inventories. We incurred excess and obsolete inventory charges of $39 and $171 for the three months ended March 31, 2021 and 2020, respectively. The change in our estimate of obsolete material that was effective as of January 1, 2021 reflects changes that have occurred in the markets we serve and the business cycles within those markets. This change in estimate did not have a material impact on our consolidated financial statements.

Leases

We account for leases in accordance with ASC Topic 842 (Leases) which was effective for us as of January 1, 2019. Upon adoption of ASC Topic 842, we elected the package of practical expedients which included the grandfathering of the lease classification that had been made under prior guidance and, accordingly, we did not re-evaluate any of our leases for classification purposes in connection with the implementation of ASC Topic 842. All our lease contracts are still being treated as operating leases. We do not currently have any lease contracts that meet the criteria to be categorized as finance leases. We did not elect the hindsight practical expedient and therefore did not reevaluate the lease terms that we used under prior guidance. The implementation of ASC Topic 842 had a significant impact on our consolidated balance sheet as a result of recording ROU assets and lease liabilities for all our multi-year leases. Under prior guidance, none of these leases had any related asset recorded on our balance sheets. The only related liability recorded on our balance sheets was the amount which represented the difference between the lease payments we had made and the straight-line rent expense we had recorded in our statements of operations. The implementation of ASC Topic 842 did not have a significant impact on our pattern of expense recognition for any of our multi-year leases.

-10-

We determine if an arrangement is a lease at inception. A lease contract is within scope if the contract has an identified asset (property, plant or equipment) and grants the lessee the right to control the use of the asset during the lease term. The identified asset may be either explicitly or implicitly specified in the contract. In addition, the supplier must not have any practical ability to substitute a different asset and would not economically benefit from doing so for the lease contract to be in scope. The lessee’s right to control the use of the asset during the term of the lease must include the ability to obtain substantially all the economic benefits from the use of the asset as well as decision-making authority over how the asset will be used. Leases are classified as either operating leases or finance leases based on the guidance in ASC Topic 842. Operating leases are included in operating lease ROU assets and operating lease liabilities in our consolidated balance sheets. Finance leases are included in property and equipment and finance lease liabilities. We do not currently have any finance leases. We do not have embedded leases nor do we have any initial direct costs related to our lease contracts.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. None of our leases provide an implicit rate; therefore, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease. We include these options in the determination of the amount of the ROU asset and lease liability when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Certain of our operating leases contain predetermined fixed escalations of minimum rentals and rent holidays during the original lease terms. Rent holidays are periods during which we have control of the leased facility but are not obligated to pay rent. For these leases, our ROU asset and lease liability are calculated including any rent holiday in the determination of the life of the lease.

We have lease agreements which contain both lease and non-lease components, which are generally accounted for separately. In addition to the monthly rental payments due, most of our leases for our offices and warehouse facilities include non-lease components representing our portion of the common area maintenance, property taxes and insurance charges incurred by the landlord for the facilities which we occupy. These amounts are not included in the calculation of the ROU assets and lease liabilities as they are based on actual charges incurred in the periods to which they apply.

Operating lease payments are included in cash outflows from operating activities on our consolidated statements of cash flows. Amortization of ROU assets is presented separately from the change in operating lease liabilities and is included in depreciation and amortization in our consolidated statements of cash flows.

We have made an accounting policy election not to apply the recognition requirements of ASC Topic 842 to short-term leases (leases with a term of one year or less at the commencement date of the lease). Lease expense for short-term lease payments is recognized on a straight-line basis over the lease term.

See Note 8 for further disclosures regarding our leases. 

Contingent Liability for Repayment of State and Local Grant Proceeds

In connection with leasing a new facility in Rochester, New York, which our subsidiary, Ambrell, occupied in May 2018, we entered into agreements with the city of Rochester and the state of New York under which we received grants totaling $463 to help offset a portion of the cost of the leasehold improvements we have made to this facility. In exchange for the funds we received under these agreements, we are required to create and maintain specified levels of employment in this location through various dates ending in 2023. If we fail to meet these employment targets, we may be required to repay a proportionate share of the proceeds. As of March 31, 2021, $370 of the total proceeds received could still be required to be repaid if we do not meet the targets. We have recorded this amount as a contingent liability which is included in other liabilities on our balance sheet. Those portions of the proceeds which are no longer subject to repayment are reclassified to deferred grant proceeds and amortized to income on a straight-line basis over the remaining lease term for the Rochester facility. Deferred grant proceeds are included in other current liabilities and other liabilities on our balance sheet and totaled $81 at March 31, 2021.

As of December 31, 2020, we were not in compliance with the employment targets as specified in the grant agreement with the city of Rochester. We applied for and received a waiver of this requirement for the year ended December 31, 2020. The waiver provided us until December 31, 2021 to come into compliance with the targets as outlined in the waiver. As of March 31, 2021, we were in compliance with those targets.

-11-

Stock-Based Compensation

We account for stock-based compensation in accordance with ASC Topic 718 (Compensation - Stock Compensation), which requires that employee share-based equity awards be accounted for under the fair value method and requires the use of an option pricing model for estimating fair value of stock options granted, which is then amortized to expense over the service periods. See further disclosures related to our stock-based compensation plan in Note 9.
10.

 

Subsequent Events

We have made an assessment of our operations and determined that there were no material subsequent events requiring adjustment to, or disclosure in, our consolidated financial statements for the nine months ended September 30, 2017.

Revenue Recognition

We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable, and collection of the related receivable is reasonably assured. Sales of our products are made through our sales employees, third-party sales representatives and distributors. There are no differences in revenue recognition policies based on the sales channel. We do not provide our customers with rights of return or exchanges. Revenue is generally recognized upon product shipment. Our customers' purchase orders do not typically contain any customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test all products manufactured as part of our quality assurance process to determine that they comply with specifications prior to shipment to a customer. To the extent that any customer purchase order contains customer-specific acceptance criteria, revenue recognition is deferred until customer acceptance.

In addition, we lease certain of our equipment to customers under non-cancellable operating leases. These leases generally have an initial term of six months. We recognize revenue for these leases on a straight-line basis over the term of the lease.

With respect to sales tax collected from customers and remitted to governmental authorities, we use a net presentation in our consolidated statement of operations. As a result, there are no amounts included in either our net revenues or cost of revenues related to sales tax.

- 8 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(2)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Product Warranties

We generally provide product warranties and record estimated warranty expense at the time of sale based upon historical claims experience. Warranty expense is included in selling expense in our consolidated statement of operations. 

Income Taxes


The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets if it is more likely than not that such assets will not be realized.

Net Earnings (Loss) Per Common Share

Net earnings (loss) per common share - basic is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding during each period. Net earnings (loss) per common share - diluted is computed by dividing net earnings (loss) by the weighted average number of common shares and common share equivalents outstanding during each period. Common share equivalents represent unvested shares of restricted stock and stock options and are calculated using the treasury stock method. Common share equivalents are excluded from the calculation if their effect is anti-dilutive.

The table below sets forth, for the periods indicated, a reconciliation of weighted average common shares outstanding - basic to weighted average common shares and common share equivalents outstanding - diluted and the average number of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their effect was anti-dilutive:

 

  

Three Months Ended
September 30,

  

Nine Months Ended
September 30,

 
  

2017

  

2016

  

2017

  

2016

 

Weighted average common shares outstanding - basic

  10,288,325   10,295,447   10,276,682   10,327,095 

Potentially dilutive securities:

                

Unvested shares of restricted stock and stock options

  62,684   23,268   50,398   17,652 

Weighted average common shares and common share
equivalents outstanding - diluted

  10,351,009   10,318,715   10,327,080   10,344,747 
                 

Average number of potentially dilutive securities excluded
from calculation

  96,000   19,800   79,753   18,277 
  

Three Months Ended
March,

 
  

2021

  

2020

 

Weighted average common shares outstanding - basic

  10,329,449   10,220,853 

Potentially dilutive securities:

        

Unvested shares of restricted stock and employee stock options

  196,377   - 

Weighted average common shares and common share equivalents outstanding - diluted

  10,525,826   10,220,853 
         

Average number of potentially dilutive securities excluded from calculation

  347,068   685,667 

 

Effect of Recently AdoptedIssued Amendments to Authoritative Accounting Guidance

In MarchJune 2016, the Financial Accounting Standards Board (the "FASB"(“FASB”) issued amendments to the current guidance onfor accounting for stock-based compensation issued to employees which is contained in ASC Topic 718 (Compensation - Stock Compensation). Thecredit losses. In November 2019, the FASB deferred the effective date of these amendments simplify several aspectsfor certain companies, including smaller reporting companies. As a result of the accounting for share-based payment transactions, includingdeferral, the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The amendments wereare effective for us for reporting periods beginning after December 15, 2022. The amendments replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires the use of a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. The amendments require a modified retrospective approach through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. We plan to adopt the amendments when they become effective for us on January 1, 2017. The implementation2023. We do not currently expect that the adoption of these amendments did notwill have a material impact on our consolidated financial statements.

In July 2015, the FASB issued amendments to update the current guidance on the subsequent measurement of inventory, which is presented in ASC Topic 330 (Inventory). The purpose of the amendments is to simplify the subsequent measurement of inventory and reduce the number of potential outcomes. It applies to all inventory other than inventory measured using last-in, first-out or the retail inventory method. Current guidance requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less a normal profit margin. The updated guidance amends this to require that an entity measure inventory within the scope of the updated guidance at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The amendments were effective for us as of January 1, 2017. The implementation of these amendments did not have a material impact on our consolidated financial statements.

- 9 -

 

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(2)(3)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)RESTRUCTURING AND OTHER CHARGES


Effect of Recently Issued Amendments to Authoritative Accounting GuidanceEMS Segment Restructuring and Facility Consolidation

In May 2017, the FASB issued amendments to the guidance on accounting for a change to the terms or conditions (modification)

On September 21, 2020, we notified employees in our Fremont, California facility of a share-based payment award. The amendments provide that an entity should account for the effects of a modification unless the fair value and vesting conditions of the modified award and the classification of the modified award (equity or liability instrument) are the same as the original award immediately before the modification. The amendments are effective for us as of January 1, 2018. Early adoption is permitted. The amendments are to be applied prospectively to an award modified on or after the adoption date. We do not expect the implementation of the amendments to have a material impact on our consolidated financial statements.

In January 2017, the FASB issued amendments to the guidance on accounting for goodwill impairment. The amendments simplify the accounting for goodwill impairment by removing Step II of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the amendments, a goodwill impairment will now be the amount by which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The amendments will be applied prospectively and are effective for us as of January 1, 2020, with early application permitted beginning January 1, 2017. We do not expect the implementation of the amendments to have a material impact on our consolidated financial statements.


In January 2017, the FASB issued amendments to clarify the current guidance on the definition of a business. The objective of the amendments is to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments are effective for us as of January 1, 2018, with early application permitted. We do not expect the implementation of these amendments to have a material impact on our consolidated financial statements.

In November 2016, the FASB issued amendments to the guidance on presentation of restricted cash within the statement of cash flows. The amendments require that restricted cash be included within cash and cash equivalents on the statement of cash flows. The amendments are effective for us as of January 1, 2018, and are to be applied retrospectively. Early application is permitted. We do not expect the implementation of these amendments to have a material impact on our consolidated financial statements.

In February 2016, the FASB issued amendments to the current guidance on accounting for lease transactions, which is presented in ASC Topic 842 (Leases). The intent of the updated guidance is to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by leases and to disclose key information about leasing arrangements. Under the new guidance, a lessee will be required to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The amendments are effective for us as of January 1, 2019. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. We are currently evaluating the impact of the implementation of these amendments on our consolidated financial statements.

In May 2014, the FASB issued new guidance on the recognition of revenue from contracts with customers. Subsequent to May, 2014, the FASB has issued additional clarifying guidance on certain aspects of this new guidance. This new guidance is presented in ASC Topic 606 (Revenue from Contracts with Customers) and will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. Companies can use either the retrospective or cumulative effect transition method. In August 2015, the FASB deferred the effective date of this new guidance for one additional year. As a result, this new guidance is effective for us as of January 1, 2018. Early application is only permitted as of the prior effective date, which in our case would be as of January 1, 2017. We currently plan to implement this new guidance on January 1, 2018 with a cumulative adjustment to retained earnings as opposed to retrospectively adjusting prior periods. Duringconsolidate all manufacturing for our EMS segment into our manufacturing operations located in Mt. Laurel, New Jersey. The consolidation was substantially completed during the fourth quarter of 2016,2020 and resulted in the termination of employment for certain employees at the Fremont location. Prior to the consolidation, our interface products were manufactured in the Fremont facility, and our manipulator and docking hardware products were manufactured in the Mt. Laurel facility. The consolidation was undertaken to better serve customers through streamlined operations and reduce the fixed annual operating costs for the EMS segment. A small engineering and sales office will be maintained in northern California.

-12-

As a result of the consolidation, we completed a preliminary reviewincurred charges for severance and other one-time termination benefits, other associated costs, including moving and production start-up costs, and charges related to exiting the facility, including an impairment charge related to the ROU asset for the lease of allthe Fremont facility, which are more fully discussed in Note 3 to our revenue streamsconsolidated financial statements in our 2020 Form 10-K. During the first quarter of 2021, we incurred $55 of additional charges associated with finalizing the integration of the manufacturing operations. All of these charges were cash charges. We expect to identify any differencescomplete the integration in timing, measurement or presentationthe second quarter of revenue recognition. Our implementation process2021 and expect to incur additional cash charges in the range of $50 to $100.

Other Restructuring Actions

During the first quarter of 2020, we recorded cash charges for severance and other one-time termination benefits of $8 related to headcount reductions in our corporate office.

Accrued Restructuring

The liability for accrued restructuring charges is ongoing; however, basedincluded in other current liabilities on the results of our assessment to date, we currently do not expectconsolidated balance sheet. Changes in the implementation of this new guidance to have a significant impact on the timing or amount of revenue we recognize in any given period in comparison to the amount recognized under current guidance.liability for accrued restructuring for the three months ended March 31, 2021 is as follows:

 

Balance - January 1, 2021

 $340 

Accruals for other costs associated with the EMS segment facility consolidation

  55 

Cash payments

  (138

)

Balance - March 31, 2021

 $257 

(3)(4)

ACQUISITIONGOODWILL AND INTANGIBLE ASSETS

 

On May 24, 2017, we completedWe have two operating segments which are also our acquisition of Ambrell, a manufacturer of precision induction heating systems. Ambrell's systems are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials, in order to transform raw materials into finished parts. The Ambrell acquisition complements our current thermal technologiesreporting units: Thermal and broadens our diverse customer base, allowing expansion within many non-ATE related markets, such as consumer product packaging, fiber-optics, automotive and other markets.

The purchase price for Ambrell was $22,000 in cash paid at closing, subject to a customary post-closing working capital adjustment. Additional consideration in the form of earnouts may be paid based upon a multiple of adjusted EBITDA for 2017 and 2018, as further discussed below. The acquisition was completed by acquiring all of the outstanding capital stock of Ambrell. Total acquisition costs incurred to complete this transaction were $880. Acquisition costs were expensed as incurred and included in general and administrative expense.

- 10 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(3)

ACQUISITION (Continued)


The acquisition of Ambrell has been accounted for as a business combination using purchase accounting, and, accordingly, the results of Ambrell have been included in our consolidated results of operations from the date of acquisition. The allocation of the Ambrell purchase price was based on estimated fair values as of May 24, 2017. The determination of fair value reflects the assistance of third-party valuation specialists, as well as our own estimates and assumptions.

The excess of the purchase price over the identifiable intangible and net tangible assets was allocated to goodwill and is not deductible for tax purposes. Goodwill is attributed to synergies that are expected to result from the operations of the combined businesses.

The total purchase price of $26,733 was comprised of:

Cash paid to acquire the capital stock of Ambrell

 $22,610 

Estimated fair value of contingent consideration

  4,123 

Total purchase price

 $26,733 

As noted above, the consideration paid for the acquisition of Ambrell includes contingent consideration in the form of earnouts based on the future adjusted EBITDA of Ambrell. Adjusted EBITDA is earnings (or loss) from operations before interest expense, benefit or provision for income taxes, depreciation and amortization, and excludes other non-recurring income and expense items as defined in the stock purchase agreement for Ambrell. The first earnout, to be paid after calendar year 2017 is completed, will be an amount equal to 8x Ambrell's adjusted EBITDA for 2017 minus the $22,000 paid at closing. The second earnout, to be paid after calendar year 2018 is completed, is an amount equal to 8x Ambrell's adjusted EBITDA for 2018 minus the sum of the $22,000 paid at closing and any earnout paid with respect to 2017. The 2017 and 2018 earnouts, in the aggregate, are capped at $18,000. To estimate the fair value of the contingent consideration at the acquisition date, an option based income approach using a Monte Carlo simulation model was utilized due to the non-linear payout structure. This resulted in an estimated fair value of $4,123, which was recorded as a contingent consideration liability as of the acquisition date.

The total purchase price of $26,733 has been allocated as follows:

Goodwill

 $12,032 

Identifiable intangible assets

  16,300 

Tangible assets acquired and liabilities assumed:

    

Cash

  648 

Trade accounts receivable

  3,621 

Inventories

  1,917 

Other current assets

  200 

Property and equipment

  614 

Accounts payable

  (1,420)

Accrued expenses

  (1,280)

Customer advances

  (554)

Deferred tax liability

  (5,345)

Total purchase price

 $26,733 

We estimated the fair value of identifiable intangible assets acquired using a combination of the income, cost and market approaches. Identifiable intangible assets acquired include customer relationships, customer backlog, technology and trademarks. We generally amortize our finite-lived intangible assets over their estimated useful lives on a straight-line basis, unless an alternate amortization method can be reliably determined. Any such alternate amortization method would be based on the pattern in which the economic benefits of the intangible asset are expected to be consumed.

- 11 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(3)

ACQUISITION (Continued)

The following table summarizes the estimated fair value of Ambrell's identifiable intangible assets and their estimated useful lives as of the acquisition date:

  



Fair
Value

  

Weighted
Average
Estimated

Useful Life

 
      

(in years)

 

Finite-lived intangible assets:

        

Customer relationships

 $9,000   9.0 

Technology

  600   9.0 

Customer backlog

  500   0.3 

Total finite-lived intangible assets

  10,100   8.6 

Indefinite-lived intangible assets:

        

Trademarks

  6,200     

Total intangible assets

 $16,300     

For the period from May 24, 2017 to September 30, 2017, Ambrell contributed $6,925 of net revenues and had net earnings of $336, which includes the impact of a $549 reduction in the amount of our contingent consideration liability during the third quarter of 2017.

The following unaudited pro forma information gives effect to the acquisition of Ambrell as if the acquisition occurred on January 1, 2016. These proforma summaries do not reflect any operating efficiencies or costs savings that may be achieved by the combined businesses. These proforma summaries are presented for informational purposes only and are not necessarily indicative of what the actual results of operations would have been had the acquisition taken place as of that date, nor are they indicative of future consolidated results of operations:

  

Three Months Ended
September 30,

  

Nine Months Ended
September 30,

 
  

2017

  

2016

  

2017

  

2016

 

Net revenues

 $17,352  $15,458  $55,040  $44,225 

Net earnings

 $2,291  $709  $6,452  $593 

Diluted earnings per share

 $0.22  $0.07  $0.61  $0.06 

The pro forma results shown above do not reflect the impact on general and administrative expense of investment advisory costs, legal costs and other costs of $880 incurred by us as a direct result of the transaction. The pro forma results shown above include a $549 reduction in the amount of our contingent consideration liability which we recorded during the third quarter of 2017.

(4)

FAIR VALUE MEASUREMENTS

ASC Topic 820 (Fair Value Measurement) establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of us. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances.

ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three-tier fair value hierarchy that distinguishes among the following:

Level 1

Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access.

Level 2

Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and models for which all significant inputs are observable, either directly or indirectly.

Level 3

Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by us in determining fair value is greatest for instruments categorized in Level 3. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

- 12 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(4)

FAIR VALUE MEASUREMENTS (Continued)


Recurring Fair Value Measurements

The contingent consideration liability on our balance sheet is measured at fair value on a recurring basis using Level 3 inputs. Our contingent consideration liability is a result of our acquisition of Ambrell on May 24, 2017, and it represents the estimated fair value of the additional cash consideration payable that is contingent upon the achievement of certain financial results by Ambrell in 2017 and 2018, as discussed more fully in Note 3. The fair value of this Level 3 instrument involves generating various scenarios for projected adjusted EBITDA over a specified time period, calculating the associated contingent consideration payments and discounting the average payments to present value. During the third quarter of 2017, we recorded a $549 reduction in the fair value of our contingent consideration liability, primarily as a result of a reduction in the projected adjusted EBITDA of Ambrell for the year ended December 31, 2017.

The following fair value hierarchy table presents information about liabilities measured at fair value on a recurring basis:

  

Amounts at

  

Fair Value Measurement Using

 
  

Fair Value

  

Level 1

  

Level 2

  

Level 3

 

As of September 30, 2017

                

Contingent consideration liability

 $3,574  $-  $-  $3,574 

Changes in the fair value of our Level 3 contingent consideration liability for the three and nine months ended September 30, 2017 were as follows:

  

Three Months
Ended

September 30, 2017

  

Nine Months
Ended

September 30, 2017

 

Balance at beginning of period

 $4,123  $- 

Contingent consideration liability established in connection with the acquisition of Ambrell

  -   4,123 

Fair value adjustment

  (549)  (549)
         

Balance at end of period

 $3,574  $3,574 

(5)

GOODWILL AND INTANGIBLE ASSETS

EMS. Goodwill and intangible assets on our balance sheets are the result of our acquisitions of Sigma Systems Corp. ("Sigma") in October 2008, Thermonics, Inc. ("Thermonics") in January 2012 and Ambrell in May 2017. All of our goodwill and intangible assets are allocated to our Thermal segment.

Goodwill

Changes in the amount

Goodwill totaled $13,738 at both March 31, 2021 and December 31, 2020 and was comprised of the carrying value of goodwill for the nine months ended September 30, 2017 are as follows:following:

 

  

Sigma

  

Thermonics

  

Ambrell

  

Total

 

Balance - January 1, 2017

 $1,656  $50  $-  $1,706 

Acquisition of Ambrell

  -   -   12,032   12,032 

Balance - September 30, 2017

 $1,656  $50  $12,032  $13,738 

Sigma

 $1,656 

Thermonics

  50 

Ambrell

  12,032 

Total

 $13,738 

 

Intangible Assets

Changes in the amount of the carrying value of finite-lived intangible assets for the ninethree months ended September 30, 2017March 31, 2021 are as follows:

 

Balance - January 1, 2017

 $365 

Acquisition of Ambrell

  10,100 

Amortization

  (916)

Balance - September 30, 2017

 $9,549 

Balance - January 1, 2021

 $5,711 

Amortization

  (304

)

Balance - March 31, 2021

 $5,407 

 

- 13 -
-13-

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(5)

GOODWILL AND INTANGIBLE ASSETS (Continued)

 

The following tables provide further detail about our intangible assets as of September 30, 2017March 31, 2021 and December 31, 2016:2020:

 

 

September 30, 2017

  

March 31, 2021

 
 

Gross
Carrying

Amount

  


Accumulated

Amortization

  

Net
Carrying

Amount

  

Gross
Carrying
Amount

  

Accumulated

Amortization

  

Net
Carrying
Amount

 

Finite-lived intangible assets:

                        

Customer relationships

 $10,480  $1,640  $8,840  $10,480  $5,191  $5,289 

Technology

  600   54   546   600   498   102 

Patents

  590   454   136   590   574   16 

Software

  270   243   27   270   270   - 

Trade name

  140   140   -   140   140   - 

Customer backlog

  500   500   - 

Total finite-lived intangible assets

  12,580   3,031   9,549   12,080   6,673   5,407 

Indefinite-lived intangible assets:

                        

Trademarks

  6,710   -   6,710   6,710   -   6,710 

Total intangible assets

 $19,290  $3,031  $16,259  $18,790  $6,673  $12,117 

 

 

December 31, 2016

  

December 31, 2020

 
 

Gross

Carrying

Amount

  


Accumulated

Amortization

  

Net
Carrying

Amount

  

Gross

Carrying

Amount

  

Accumulated

Amortization

  

Net
Carrying

Amount

 

Finite-lived intangible assets:

                        

Customer relationships

 $1,480  $1,328  $152  $10,480  $4,912  $5,568 

Technology

  600   477   123 

Patents

  590   424   166   590   570   20 

Software

  270   223   47   270   270   - 

Trade name

  140   140   -   140   140   - 

Total finite-lived intangible assets

  2,480   2,115   365   12,080   6,369   5,711 

Indefinite-lived intangible assets:

                        

Sigma trademark

  510   -   510 

Trademarks

  6,710   -   6,710 

Total intangible assets

 $2,990  $2,115  $875  $18,790  $6,369  $12,421 

 

We generally amortize our finite-lived intangible assets over their estimated useful lives on a straight-line basis, unless an alternate amortization method can be reliably determined. Any such alternate amortization method would be based on the pattern in which the economic benefits of the intangible asset are expected to be consumed. None of our intangible assets have any residual value.

 

Total amortization expense for our finite-lived intangible assets was $916$304 and $173,$311, respectively, for the ninethree months ended September 30, 2017March 31, 2021 and 2016.2020. The following table sets forth the estimated annual amortization expense for each of the next five years:

 

2017 (remainder)

 $246 

2018

 $1,102 

2019

 $1,257 

2020

 $1,233 

2021

 $1,227 

2021 (remainder)

 $923 

2022

 $1,167 

2023

 $1,067 

2024

 $980 

2025

 $905 

 

-14-

(6)(5)

REVENUE FROM CONTRACTS WITH CUSTOMERS

The following tables provide additional information about our revenue from contracts with customers, including revenue by customer and product type and revenue by market. See also Note 13 for information about revenue by operating segment and geographic region.

  

Three Months Ended
March 31,

 
  

2021

  

2020

 

Net revenues by customer type:

        

End user

 $17,660  $9,922 

OEM/Integrator

  1,896   1,308 
  $19,556  $11,230 
         

Net revenues by product type:

        

Thermal test

 $4,305  $4,147 

Thermal process

  5,566   3,748 

Semiconductor production test

  8,320   1,825 

Service/other

  1,365   1,510 
  $19,556  $11,230 
         

Net revenues by market:

        

Semi Market

 $13,320  $5,011 

Multimarket:

        

Industrial

  3,828   4,227 

Defense/aerospace

  1,129   1,408 

Telecommunications

  340   411 

Other Multimarket

  939   173 
  $19,556  $11,230 

There was no change in the amount of the allowance for doubtful accounts for the three months ended March 31, 2021.

-15-

(6)

MAJOR CUSTOMERS

 

During the ninethree months ended September 30, 2017 and 2016,March 31, 2021, Texas Instruments Incorporated accounted for 12% and 11%16% of our consolidated net revenues, respectively.revenues. While both of our operating segments sold products to this customer, these revenues were primarily generated by our EMS segment. During the nine months ended September 30, 2017 and 2016, Hakuto Co., Ltd., one of our distributors, accounted for 11% and 13% of our consolidated net revenues, respectively. These revenues were generated by our Thermal segment. No other customers accounted for 10% or more of our consolidated net revenues during the ninethree months ended September 30, 2017 and 2016.March 31, 2021. During the three months ended March 31, 2020, no customer accounted for 10% or more of our consolidated net revenues.

 

- 14 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(7)

INVENTORIES

 

Inventories held at September 30, 2017March 31, 2021 and December 31, 20162020 were comprised of the following:

 

 

September 30,
2017

  

December 31,
2016

  

March 31,
2021

  

December 31,
2020

 

Raw materials

 $3,892  $2,695  $5,980  $5,371 

Work in process

  1,013   728   992   1,085 

Inventory consigned to others

  72   81   44   45 

Finished goods

  1,056   172   1,196   975 

Total inventories

 $6,033  $3,676  $8,212  $7,476 

 

 

(8)

DEBTLEASES

 

We lease our offices, warehouse facilities and certain equipment under non-cancellable operating leases which expire at various dates through 2031. Total operating lease and short-term lease costs for the three months ended March 31, 2021 and 2020 were as follows:

  

Three Months Ended

March 31,

 
  

2021

  

2020

 
         

Operating lease cost

 $324  $392 

Short-term lease cost

 $8  $12 

The following is additional information about our leases as of March 31, 2021:

Range of remaining lease terms (in years)

  0.1to10.0 

Weighted average remaining lease term (in years)

    6.4 

Weighted average discount rate

    4.3%

-16-

Maturities of lease liabilities as of March 31, 2021 were as follows:

2021 (remainder)

 $1,074 

2022

  1,402 

2023

  1,413 

2024

  1,394 

2025

  723 

Thereafter

  1,845 

Total lease payments

 $7,851 

Less imputed interest

  (938

)

Total

 $6,913 

Supplemental Cash Flow Information

Total amortization of ROU assets for the three months ended March 31, 2021 and 2020 was $280 and $325, respectively.

(9)

DEBT

Letters of Credit

We have issued letters of credit as the security deposits for certain of our domestic leases. These letters of credit are secured by pledged certificates of deposit which are classified as Restricted Certificates of Deposit on our balance sheets. The terms of our leases require us to renew these letters of credit at least 30 days prior to their expiration dates for successive terms of not less than one year until lease expiration.

Our outstanding letters of credit at September 30, 2017March 31, 2021 and December 31, 20162020 consisted of the following:

 

  


L/C

 


Lease

 

Letters of Credit
Amount Outstanding

       

Letters of Credit
Amount Outstanding

 

Original L/C
Issue Date

 

Expiration
Date

 

Expiration
Date

 

September 30,
2017

  

December 31,
2016

 

Facility

Original L/C
Issue Date

 

L/C
Expiration
Date

 

Lease
Expiration
Date

 

March 31,
2021

  

December 31,
2020

 

Mt. Laurel, NJ

3/29/2010

 

3/31/2018

 

4/30/2021

 $125  $125 

3/29/2010

 

4/30/2022

 

4/30/2031

 $90  $90 

Mansfield, MA

10/27/2010

 

11/08/2018

 

8/23/2021

  50   50 

10/27/2010

 

12/31/2024

 

12/31/2024

  50   50 
      $175  $175       $140  $140 

 

Line of Credit

As discussed more fully in Note 10 to our consolidated financial statements in our 2020 Form 10-K, on April 10, 2020, we entered into a Loan and Security Agreement (the “Agreement”) with M&T Bank (“M&T”). Under the terms of the Agreement, M&T has provided us with a $7,500 revolving credit facility which is guaranteed by our subsidiaries. This facility was put in place to provide us with additional liquidity in response to the current business environment, as a result of the COVID-19 pandemic. This facility, which had no outstanding balance, was set to mature on April 9, 2021. As discussed in Note 14, we modified this facility on April 10, 2021 and extended it as modified through April 9, 2024.

(9)(10)

STOCK-BASED COMPENSATION

 

As of September 30, 2017,March 31, 2021, we havehad unvested restricted stock awards and stock options outstanding which were granted under stock-based employee compensation plans that are described more fully in Note 1213 to the consolidated financial statements in our 20162020 Form 10-K.

As of September 30, 2017, total unrecognized compensation expense related toOur unvested restricted stock awards and stock options was $691.are accounted for based on their grant date fair value. As of March 31, 2021, total compensation expense to be recognized in future periods is $2,787. The weighted average period over which this expense is expected to be recognized is 2.8 years. The following table shows the allocation of the compensation expense we recorded during the three and nine months ended September 30, 2017March 31, 2021 and 2016,2020, respectively, related to stock-based compensation:

 

 

Three Months Ended
September 30,

  

Nine Months Ended
September 30,

  

Three Months Ended
March 31,

 
 

2017

  

2016

  

2017

  

2016

  

2021

  

2020

 

Cost of revenues

 $1  $2  $5  $7  $-  $- 

Selling expense

  -   1   -   4   3   3 

Engineering and product development expense

  1   3   5   8   10   10 

General and administrative expense

  104   38   282   203   256   174 
 $106  $44  $292  $222  $269  $187 

 

There was no stock-based compensation expense capitalized in the ninethree months ended September 30, 2017March 31, 2021 or 2016.

2020.

-17-

Restricted Stock Awards

We record compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and amortize the expense over the vesting period. Restricted stock awards generally vest over four years. However, during January 2016, we granted 22,500 shares of restricted stock toyears for employees and over one year for our independent directors which vested 100% upon the re-election of these directors at our annual meeting of stockholders in June 2016. The total compensation expense related to the shares granted in 2016 was $98, and it was recorded upon the re-election of these directors. In March 2017, we granted 22,500 shares of restricted stock to these same directors. These shares vested 25% upon the grant date and will vest an additional 25%(25% at each of March 31, June 30, September 30, and December 31 2017.of the year in which they were granted).

On August 24, 2020, our new President and CEO received two restricted stock awards totaling 141,610 shares valued at $650 as of the date of grant, which was also his hire date. Of the total shares awarded, 66,448 shares vest over 4 years (25% at each anniversary) and 75,162 vest on the third anniversary of the grant date at a vesting percentage that could range from 0% to 150% of the number of shares awarded on August 24, 2020. The total compensationfinal vesting percentage will be based on the achievement of certain performance metrics, including net revenue compound annual growth rate and diluted earnings per share excluding amortization of intangibles, for specified time periods as determined by the Compensation Committee of our Board of Directors. As of March 31, 2021, we have estimated that these shares will vest at 100% of the original amount awarded and are recording expense based on this estimate on a straight-line basis over the three-year vesting period. Our estimate of the final expected vesting percentage is reassessed and adjusted, as needed, at the end of each reporting period.

On March 10, 2021 we issued restricted stock awards totaling 18,000 shares to members of the senior management within our operating segments. These shares will vest on the third anniversary of the grant date at a vesting percentage that could range from 0% to 150% of the number of shares awarded on March 10, 2021. The final vesting percentage will be based on the achievement of certain performance metrics related to the operating results of the business units for which these members of management are responsible. As of March 31, 2021, we have estimated that these shares will vest at 100% of the original amount awarded and are recording expense based on this estimate on a straight-line basis over the three-year vesting period. Our estimate of the final expected vesting percentage is $143reassessed and it will be recordedadjusted, as needed, at the shares vest during 2017.end of each reporting period.

- 15 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(9)

STOCK-BASED COMPENSATION (Continued)

 

The following table summarizes the activity related to unvested shares of restricted stock for the ninethree months ended September 30, 2017:March 31, 2021:

 

 


Number
of Shares

  

Weighted
Average
Grant Date

Fair Value

  

Number
of Shares

  

Weighted
Average
Grant Date
Fair Value

 

Unvested shares outstanding, January 1, 2017

  97,025  $4.04 

Unvested shares outstanding, January 1, 2021

  237,155  $4.93 

Granted

  64,000   6.48   81,468   10.62 

Vested

  (45,975)  4.70   (22,200

)

  8.56 

Forfeited

  -   -   -   - 

Unvested shares outstanding, September 30, 2017

  115,050   5.13 

Unvested shares outstanding, March 31, 2021

  296,423   6.22 

 

The total fair value of the shares that vested during the ninethree months ended September 30, 2017March 31, 2021 and 20162020 was $290$244 and $138,$155, respectively, as of the vesting dates of these shares.

Stock Options

We record compensation expense for stock options based on the fair market value of the options as of the grant date. No option may be granted with an exercise period in excess of ten years from the date of grant. Generally, stock options will be granted with an exercise price equal to the fair market value of our stock on the date of grant and will vest over four years.

The fair value for stock options granted during the ninethree months ended September 30, 2017March 31, 2021 and 20162020 was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 

  

2017

  

2016

 

Risk-free interest rate

  2.14%  1.30%

Dividend yield

  0.00%  0.00%

Expected common stock market price volatility factor

  .39   .40 

Weighted average expected life of stock options (years)

  6   4 

  

2021

  

2020

 

Risk-free interest rate

  1.00

%

  0.48

%

Dividend yield

  0.00

%

  0.00

%

Expected common stock market price volatility factor

  .49   .43 

Weighted average expected life of stock options (years)

  6.25   6.25 

-18-

 

The per share weighted average fair value of stock options issued during the ninethree months ended September 30, 2017March 31, 2021 and 20162020 was $2.64$5.09 and $1.43,$1.55, respectively.

The following table summarizes the activity related to stock options for the ninethree months ended September 30, 2017:March 31, 2021:

 

 


Number
of Shares

  

Weighted
Average
Grant Date

Fair Value

  

Number
of Shares

  

Weighted
Average
Grant Date
Fair Value

 

Options outstanding, January 1, 2017 (none exercisable)

  19,800  $4.37 

Options outstanding, January 1, 2021 (204,630 exercisable)

  438,200  $6.25 

Granted

  96,000   6.35   164,800   10.62 

Exercised

  -   -   (99,740

)

  7.19 

Forfeited

  -   -   -   - 

Options outstanding, September 30, 2017 (4,950 exercisable)

  115,800   6.01 

Options outstanding, March 31, 2021 (144,265 exercisable)

  503,260   7.49 

 

 

(10)(11)

STOCK REPURCHASE PLAN

 

As discussed further in our 2016 Form 10-K, on October 27, 2015,On July 31, 2019, our Board of Directors authorized the repurchase of up to $5,000$3,000 of our common stock from time to time on the open market, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"“Exchange Act”), or in privately negotiated transactions pursuant to a newly authorized stock repurchase plan (the "2015“2019 Repurchase Plan"Plan”). Repurchases may be made under a Rule 10b5-1 plan entered into with RW Baird & Co., which would permit shares to be repurchased when we might otherwise be precluded from doing so under insider trading laws and our internal trading windows. The 20152019 Repurchase Plan does not obligate us to repurchasepurchase any particular amount of common stock and may be suspended or discontinued at any time without prior notice. The 20152019 Repurchase Plan is funded using our operating cash flow or available cash.

During Purchases began on September 18, 2019 under this plan. On March 2, 2020, we suspended repurchases under the nine months ended September 30, 2017 and 2016,2019 Repurchase Plan. For the term of the 2019 Repurchase Plan through March 31, 2021, we repurchased 13,883 and 209,271 shares, respectively, at a cost of $62 and $841, respectively. As of September 30, 2017, we hadhave repurchased a total of 297,020243,075 shares at a cost of $1,195 under the 2015 Repurchase Plan.$1,216, which includes fees paid to our broker of $6. All of the repurchased shares were retired.

 

- 16 -

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(11)(12)

EMPLOYEE BENEFIT PLANS

 

We have defined contribution 401(k) plans for our employees who work in the U.S. All permanent employees of inTEST Corporation, inTEST EMS LLC, Temptronic Corporation (“Temptronic”) and inTEST Silicon Valley Corporation who are at least 18 years of age are eligible to participate in the inTEST Corporation Incentive Savings Plan. We match employee contributions dollar for dollar up to 10% of the employee's annual compensation, with a maximum limit of $5. Employer contributions vest ratably over four years. Matching contributions are discretionary. For the ninethree months ended September 30, 2017March 31, 2021 and 2016, we recorded $2992020, expense under the plan was $171 and $311 of expense for matching contributions,$165, respectively.

All permanent employees of Ambrell are immediately eligible to participate in the Ambrell Corporation Savings & Profit Sharing Plan (the "Ambrell Plan") upon employment and are eligible for employer matching contributions after completing one yearsix months of service, as defined in the Ambrell Plan. The Ambrell Plan allows eligible employees to make voluntary contributions up to 100% of compensation, up to the federal government contribution limits. We will make a matching contribution of 25%50% of each employee's contributions up to a maximum of 2%10% of suchthe employee's annual compensation. Fromdeferral with a maximum limit of $5. For the date of acquisition through September 30, 2017, we made matching contributions of $21.three months ended March 31, 2021 and 2020, expense under the plan was $43 and $17, respectively.

 

 

(12)(13)

SEGMENT INFORMATION

 

As discussed in Note 1, during 2016, we reorganized our business from three product segments (Thermal Products, Mechanical Products and Electrical Products) into two product segments (Thermal and EMS). Accordingly, effective January 1, 2017, weWe have two reportable segments, Thermal and EMS, which are also our reporting units. Prior period information has been reclassified to be comparable to the presentation for 2017.

Thermal includes the operations of Temptronic, Thermonics, Sigma, inTEST Thermal Solutions GmbH (Germany), inTEST Pte, Limited (Singapore) and Ambrell, which we acquired in May 2017, as discussed in Note 3.Ambrell. Sales of this segment consist primarily of temperature management systems which we design, manufacture and market under our Temptronic, Thermonics and Sigma product lines, and precision induction heating systems which are designed, manufactured and marketed by Ambrell. In addition, this segment provides post-warranty service and support.

EMS includes the operations of our manufacturing facilities in Mt. Laurel, New Jersey and, prior to the consolidation of manufacturing operations late in the fourth quarter of 2020, Fremont, California. Sales of this segment consist primarily of manipulator, docking hardware and tester interface products, which we design, manufacture and market.

-19-

We operate our business worldwide and sell our products both domestically and internationally. Both of our segments sell to semiconductor manufacturers, third-party test and assembly houses and ATE manufacturers. Thermal also sells into a variety of markets outside of the ATE market,Semi Market, including the automotive, consumer electronics, consumer product packaging, defense/aerospace, energy, fiber optics,medical, industrial, telecommunications and other markets.

 

  

Three Months Ended
September 30,

  

Nine Months Ended
September 30,

 
  

2017

  

2016

  

2017

  

2016

 

Net Revenues:

                

Thermal

 $11,470  $6,641  $28,440  $17,429 

EMS

  5,882   4,182   18,980   12,526 
  $17,352  $10,823  $47,420  $29,955 

Earnings (loss) before income tax expense (benefit):

                

Thermal

 $1,539  $1,402  $4,735  $2,709 

EMS

  1,594   374   5,455   733 

Corporate

  (292)  (55)  (1,841)  (848)
  $2,841  $1,721  $8,349  $2,594 

Net earnings (loss):

                

Thermal

 $1,183  $888  $3,228  $1,737 

EMS

  1,021   236   3,471   469 

Corporate

  (186)  (34)  (1,158)  (549)
  $2,018  $1,090  $5,541  $1,657 

 

September 30,
2017

  

December 31,
2016

  

Three Months Ended
March 31,

 

Identifiable assets:

        
 

2021

  

2020

 

Net Revenues:

Net Revenues:

 

Thermal

 $49,443  $19,893  $11,055  $9,334 

EMS

  10,771   22,951   8,501   1,896 
 $60,214  $42,844  $19,556  $11,230 

Earnings (loss) before income tax expense (benefit):

Earnings (loss) before income tax expense (benefit):

 

Thermal

 $103  $(426

)

EMS

  2,620   (1,004

)

Corporate

  (145

)

  37 
 $2,578  $(1,393

)

Net earnings (loss):

Net earnings (loss):

 

Thermal

 $88  $(350

)

EMS

  2,248   (824

)

Corporate

  (124

)

  31 
 $2,212  $(1,143

)

 

- 17 -

  

March 31,
2021

  

December 31,
2020

 

Identifiable assets:

        

Thermal

 $52,096  $50,782 

EMS

  13,671   9,667 

Corporate

  1,359   1,581 
  $67,126  $62,030 

 

inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)
(In thousands, except share and per share data)

(12)

SEGMENT INFORMATION (Continued)


The following table provides information about our geographic areas of operation. Net revenues from unaffiliated customers are based on the location to which the goods are shipped.

 

  

Three Months Ended
September 30,

  

Nine Months Ended
September 30,

 
  

2017

  

2016

  

2017

  

2016

 

Net revenues:

                

U.S.

 $4,746  $3,268  $12,212  $8,898 

Foreign

  12,606   7,555   35,208   21,057 
  $17,352  $10,823  $47,420  $29,955 

 

September 30,
2017

  

December 31,
2016

  

Three Months Ended
March 31,

 

Property and equipment:

        
 

2021

  

2020

 

Net revenues:

        

U.S.

 $1,003  $691  $5,747  $5,719 

Foreign

  541   253   13,809   5,511 
 $1,544  $944  $19,556  $11,230 

 

- 18 -

  

March 31,
2021

  

December 31,
2020

 

Property and equipment:

        

U.S.

 $2,245  $2,053 

Foreign

  293   297 
  $2,538  $2,350 

 

inTEST CORPORATION

(14)

SUBSEQUENT EVENTS

On April 10, 2021, we amended our Agreement with M&T, with the execution of the Second Amendment to the Agreement (the “Second Amendment”). Under the terms of the Second Amendment, the maximum amount available under the revolving credit facility was increased from $7,500 to $10,000, and an unused facility fee of fifteen basis points per annum was added. This facility was amended to provide us with additional liquidity to operate our business, if needed. This facility will mature on April 9, 2024.

-20-

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Risk Factors and Forward-Looking Statements

In addition to historical information, this report andQuarterly Report on Form 10-Q for the period ended March 31, 2021 (this “Report”), including this management’s discussion and analysis (“MD&A”), contains statements relating to possible future events and results that are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of our plans, strategies and intentions, or our future performance or goals that are based upon management's current expectations. Our forward-looking statements can often be identified by the use of forward-looking terminology such as "believes," "expects," "intends," "may," “could,” "will," "should," “plans”"plans," “projects,” “forecasts,” “seeks,” “anticipates,” “goal,” “objective,” “target,” “future,” “outlook,” “vision,” or "anticipates"variations of such words or similar terminology. See Part I, Item 1 - "Business - Cautionary Statement Regarding Forward-Looking Statements" in our 2016 Form 10-K for examples ofInvestors and prospective investors are cautioned that such forward-looking statements made in this report which may be "forward-looking statements."are only projections based on current estimations. These statements involve risks and uncertainties and are based onupon various assumptions. Although we believe that our expectations are based on reasonable assumptions, investors and prospective investors are cautioned that such statements are only projections, and there cannot be any assurance that these events or results will occur. We undertake no obligation to update the information in this report and MD&A to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

Information about the primarySuch risks and uncertainties that could cause our actual future results to differ materially from our historic results or the results described in the forward-looking statements made in this report or presented elsewhere by management from time to timeinclude, but are included in Part I, Item 1A - "Risk Factors" in our 2016 Form 10-K. not limited to:

the impact of COVID-19 on our business, liquidity, financial condition and results of operations;

our ability to successfully consolidate our EMS manufacturing operations without any impact on customer shipments, quality or the level of our warranty claims and to realize the benefits of the consolidation;

indications of a change in the market cycles in the Semi Market or other markets we serve;

developments and trends in the Semi Market, including changes in the demand for semiconductors;

the loss of any one or more of our largest customers, or a reduction in orders by a major customer;

changes in the rate of, and timing of, capital expenditures by our customers;

the availability of materials used to manufacture our products;

the impact of interruptions in our supply chain caused by external factors;

the sufficiency of cash balances, lines of credit and net cash from operations;

stock price fluctuations;

the possibility of future acquisitions or dispositions and the successful integration of any acquired operations;

ability to borrow funds or raise capital to finance major potential acquisitions;

the success of our strategy to diversify our business by entering markets outside the Semi Market, including the automotive, defense/aerospace, industrial, medical, telecommunications and other markets and changes in demand in these markets

competitive pricing pressures

the development of new products and technologies by us or our competitors;

effects of exchange rate fluctuations;

progress of product development programs;

the anticipated market for our products;

the availability of and retention of key personnel or our ability to hire personnel at anticipated costs;

general economic conditions both domestically and globally;

other projections of net revenues, taxable earnings (loss), net earnings (loss), net earnings (loss) per share, capital expenditures and other financial items; and

other risk factors included in Part I, Item 1A - "Risk Factors" in our 2020 Form 10-K.

Material changes to such risk factors may be reported in subsequent Quarterly Reports on Form 10-Q in Part II, Item 1A. There have been no such changesThese risks and uncertainties, among others, could cause our actual future results to differ materially from the risk factors set forththose described in our 2016 Form 10-K. 

Overview

Inforward-looking statements or from our prior results. Any forward-looking statement made by us in this reportReport is based only on information currently available to us and MD&A, "we," "us," "our," andspeaks to circumstances only as of the "Company" referdate on which it is made. We are not obligated to inTEST Corporation and its consolidated subsidiaries. update these forward-looking statements, even though our situation may change in the future.

Overview

This MD&A should be read in conjunction with the accompanying consolidated financial statements.

We are a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. We manage our business as two operating segments: Thermal and EMS. Our Thermal segment designs, manufactures and sells our thermal test and thermal process products while our EMS segment designs, manufactures and sells our semiconductor test products.

-21-

Our EMS segment sells its products to semiconductor manufacturers and third-party test and assembly houses (end user sales) and to ATE manufacturers (“OEM sales”), who ultimately resell our equipment with theirs to both semiconductor manufacturers and third-party test and assembly houses. These sales all fall within the ATE sector of the broader semiconductor market. Our Thermal segment sells its products to many of these same types of customers; however, it also sells to customers in the wafer processing sector within the broader semiconductor market and to customers in a variety of other markets outside the semiconductor market, including the automotive, defense/aerospace, industrial (including consumer products packaging, fiber optics and other sectors within the broader industrial market), medical and telecommunications markets.

Both of our operating segments have multiple products that we design, manufacture and market to our customers. Due to a number of factors, our products have varying levels of gross margin. These factors include, for example, the amount of engineering time required to develop the product, the market or customer to which we sell the product and the level of competing products available from other suppliers. The needs of our customers ultimately determine the products that we sell in a given time period. Therefore, the mix of products sold in a given period can change significantly when compared against the prior period. As a result, our consolidated gross margin may be significantly impacted by a change in the mix of products sold in a particular period.

Markets

We refer to the semiconductor market, including the more specialized semiconductor ATE and wafer processing sectors within the broader semiconductor market, as the “Semi Market.” All other markets are designated as “Multimarket.” Business within our Thermal segment can fall into either the Semi Market or Multimarket, depending upon how our customers utilize our products or upon their respective applications.

While the Semi Market represents the historical roots of inTEST and remains a very important component of our business, Multimarket is where we have focused our strategic growth efforts in the last several years. Our goal was to grow our business, both organically and resultsthrough acquisition, in these markets as we believe these markets have historically been less cyclical than the Semi Market. Moving forward, with the launch of operations areour new strategic plan which is discussed in Part 1, Item 1 under “Our Strategies” in our 2020 Form 10-K, we intend to broaden our strategic growth efforts to target both organic and inorganic growth in all of our currently served markets, which includes the Semi Market. Our goal is to further expand our existing product lines, strengthen our positions in served markets and drive expansion into new markets.

Prior to our acquisition of Ambrell in May 2017, we offered only highly specialized engineering solutions used for testing applications in Multimarket, the demand for which is limited and which varies significantly from period to period. Our acquisition of Ambrell not only provided expansion into new markets but also broadened our product offerings to include products sold into process or manufacturing applications. Historically, Ambrell sold its precision induction heating systems almost exclusively to customers in the industrial market but since 2018, has also had significant sales into the Semi Market. Overall, however, the acquisition of Ambrell has helped to diversify our customer base.

The portion of our business that is derived from the Semi Market is substantially dependent upon the demand for ATE by semiconductor manufacturers and companies that specialize in the testing of ICs. As further discussed below, on May 24, 2017, we acquiredintegrated circuits or, for Ambrell, which sells its products almost exclusively to customers in the industrial market, which is a non-ATE market. We expect that the acquisition of Ambrell will significantly reduce our dependence on customers in the ATE market. We expect that our future orders and net revenues will be approximately equally split between the ATE and non-ATE markets.demand for wafer processing equipment. Demand for ATE or wafer processing equipment is driven by semiconductor manufacturers that are opening new, or expanding existing, semiconductor fabrication facilities or upgrading equipment, which in turn is dependent upon the current and anticipated market demand for semiconductors and products incorporating semiconductors. Such market demand can be the result of market expansion, development of new technologies or redesigned products to incorporate new features, or the replacement of aging equipment. In addition, we continue to focus on design improvements and new approaches for our own products whichthat contribute to our net revenues as our customers adopt these new products.

In the past, the semiconductor industrySemi Market has been highly cyclical with recurring periods of oversupply, which often have a severeseverely impact on the semiconductor industry'sSemi Market's demand for ATE, including the products we manufacture.manufacture and sell into the market. This cyclicality can cause wide fluctuations in both our orders and net revenues and, depending on our ability to react quickly to these shifts in demand, can significantly impact our results of operations. ATE marketMarket cycles are difficult to predict and, in recent years have become more volatile and, in certain cases, shorter in duration. Because the market cyclesbecause they are generally characterized by sequential periods of growth or declines in orders and net revenues during each cycle, year over year comparisons of operating results may not always be as meaningful as comparisons of periods at similar points in either up or down cycles. These periods of heightened or reduced demand can shift depending on various factors impacting both our customers and the markets that they serve. In addition, during both downward and upward cycles in our industry,the Semi Market, in any given quarter, the trend in both our orders and net revenues can be erratic. This can occur, for example, when orders are canceled or currently scheduled delivery dates are accelerated or postponed by a significant customer or when customer forecasts and general business conditions fluctuate during a quarter.

In addition to being cyclical, the ATE market has also developed a seasonal pattern in the last several years, with the second and third quarters being the periods of strong demand and the first and fourth quarters being periods of weakened demand. We believe this change has been driven by the strong demand for consumer products containing semiconductor content sold during the year-end holiday shopping season.

 

- 19 -
-22-

 

inTEST CORPORATION

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)


Third-partyThird party market share statistics are not available for the products we manufacture and sell into the ATE market;Semi Market; therefore, comparisons of period over period changes in our market share are not easily determined. As a result, it is difficult to ascertain if ATE marketSemi Market volatility in any period is the result of macro-economic or customer-specific factors impacting ATE marketSemi Market demand, or if we have gained or lost market share to a competitor during the period.

As part of our ongoing strategy to reduce the impact of ATE market volatility on our business operations, we continue to diversify our served markets to address the thermal test requirements of several other markets outside the ATE market. These include the automotive, consumer electronics, consumer product packaging, defense/aerospace, energy, fiber optics, industrial, telecommunications and other markets. We believe that these markets usually are less cyclical than the ATE market.

While market share statistics exist for some of the markets we serve outside the ATE market, due to the nature of our highly specialized product offerings in these non-ATE markets, we do not expect broad market penetration in many of these markets and, therefore, do not anticipate developing meaningful market shares in these non-ATE markets. In addition, our orders and net revenues in any given period in these markets do not necessarily reflect the overall trends in these non-ATE markets due to our limited market shares. Consequently, we are continuing to evaluate buying patterns and opportunities for growth in these non-ATE markets that may affect our performance. The level of our orders and net revenues from these non-ATE markets has varied in the past, and we expect will vary significantly in the future, as we work to build our presence in these markets and establish new markets for our products. As previously mentioned, Ambrell, which we acquired in May 2017, sells its products almost exclusively to customers in the industrial market, which is one of the non-ATE markets we serve. We expect that the acquisition of Ambrell will significantly increase our orders and net revenues from markets outside the ATE market. As a result, we expect that our future orders and net revenues will be approximately equally split between the ATE and non-ATE markets.

While the majorityhalf of our orders and net revenues are derived from the ATE market,Semi Market, and our operating results do not alwaysgenerally follow the overall trend in the ATE marketSemi Market, in any given period.period we may experience anomalies that cause the trend in our net revenues to deviate from the overall trend in the Semi Market. We believe that these anomalies may be driven by a variety of factors within the ATE market,Semi Market, including, for example, changing product requirements, longer time periods between new product offerings by original equipment manufacturers ("OEMs")OEMs and changes in customer buying patterns. In particular, demand for our mechanical and electrical products, which are sold exclusively within the ATE market, and our operating margins in these product segments have been affected by shifts in the competitive landscape, including (i) customers placing heightened emphasis on shorter lead times (which places increased demands on our available engineering and production capacity increasing unit costs) and ordering in smaller quantities (which prevents us from acquiring component materials in larger volumes at lower cost and increasing unit costs), (ii) the practice of OEMs specifying other suppliers as primary vendors, with less frequent opportunities to compete for such designations, (iii) the in-house manufacturing activities of OEMs building certain products we have historically sold to them, including manipulators, docking hardware and tester interfaces, which has had the impact of significantly reducing the size of the available market for those certain products, (iv) the role of third-party test and assembly houses in the ATE market and their requirement of products with a greater range of use at the lowest cost, (v) customer supply chain management groups demanding lower prices and spreading purchases across multiple vendors, and (vi) certain competitors aggressively reducing their products' sales prices (causing us to either reduce our products' sales prices to be successful in obtaining the sale or causing loss of the sale).

In addition, in recent periods, we have seen instances wherewhen demand for ATEwithin the Semi Market is not consistent for each of our productoperating segments or for any given product within a particular productoperating segment. This inconsistency in demand for ATE can be driven by a number of factors but, in most cases, we have found that the primary reason is unique customer-specific changes in demand for certain products driven by the needs of their customers or markets served. Recently this has become more pronounced for our sales into the wafer processing sector within the broader semiconductor market due to the limited market penetration we have into this sector and the variability of orders we have experienced from the few customers we support. These shifts in market practices and customer-specific needs have had, and may continue to have, varying levels of impact on our operating results and are difficult to quantify or predict from period to period. Management has taken, and will continue to take, such actions it deems appropriate to adjust our strategies, products and operations to counter such shifts in market practices as they become evident.

- 20 -

inTEST CORPORATION

 

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)As previously mentioned, as part of our ongoing strategy to grow our business, we continue to diversify our served markets to address the thermal test and thermal process requirements of several markets outside the Semi Market. These include the automotive, defense/aerospace, industrial, medical, telecommunications and other markets, which we refer to as Multimarket. We believe that these markets are usually less cyclical than the Semi Market. While market share statistics exist for some of these markets, due to the nature of our highly specialized product offerings in these markets, we do not expect broad market penetration in many of these markets and therefore do not anticipate developing meaningful market shares in most of these markets.

 

In addition, because of our limited market share, our Multimarket orders and net revenues in any given period do not necessarily reflect the overall trends in the markets within Multimarket. Consequently, we are continuing to evaluate buying patterns and opportunities for growth in Multimarket that may affect our performance. The level of our Multimarket orders and net revenues has varied in the past, and we expect will vary significantly in the future, as we work to build our presence in Multimarket and establish new markets for our products.

AcquisitionRestructuring and Other Charges

On May 24, 2017,September 21, 2020, we notified employees in our Fremont, California facility of a plan to consolidate all manufacturing for our EMS segment into our manufacturing operations located in Mt. Laurel, New Jersey. The consolidation was substantially completed during the acquisitionfourth quarter of Ambrell by acquiring all2020 and resulted in the termination of certain employees at the outstanding capital stock of Ambrell. Ambrell is a manufacturer of precision induction heating systems. Ambrell's systemsFremont location. Prior to the consolidation, our interface products were manufactured in the Fremont facility, and our manipulator and docking hardware products were manufactured in the Mt. Laurel facility. The consolidation was undertaken to better serve customers through streamlined operations and reduce the fixed annual operating costs for the EMS segment. A small engineering and sales office will be maintained in northern California. The costs related to these actions are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials,included in order to transform raw materials into finished parts. The Ambrell acquisition complements our current thermal technologies and broadens our diverse customer base, allowing expansion within many non-ATE related markets, such as consumer product packaging, fiber-optics, automotiverestructuring and other markets. This acquisition has been accounted for as a business combination using purchase accounting. The purchase price for Ambrell was $22.6 millioncharges on our consolidated statement of operations and are discussed in cash. Additional considerationmore detail in the form of earnouts may be paid based upon a multiple of adjusted EBITDA for 2017 and 2018. The 2017 and 2018 earnouts, in the aggregate, are capped at $18 million. For further discussion of the acquisition, see Note 3 to our consolidated financial statements.

statements in this Report and in our 2020 Form 10-K.

The EMS facility consolidation resulted in the termination of certain employees at the Fremont location, including all of our interface product line assembly staff who were located at that facility. As a result of transitioning our interface manufacturing operations to New Jersey, we have hired new production staff for this product line in our Mt. Laurel facility. These new employees are being trained to assemble our products which may impact customer shipments and quality of our interface products over the next several months. In addition, we have recently experienced difficulty in hiring personnel at the costs projected in our forecasts. This has resulted in the need to increase the labor rates offered for certain positions. If we cannot find savings in other areas or increase the price for which we sell our products in an amount sufficient to cover these additional labor costs, we may experience reduced margins in future periods. See “Risks Related to Our Business Operations” in Item 1A “Risk Factors” of our 2020 Form 10-K.

-23-

Orders and Backlog

The following table sets forth, for the periods indicated, a breakdown of the orders received by productoperating segment and market (in thousands).

 

  

Three
Months Ended

September 30,

  

Change

  

Three
Months Ended

June 30,

  

Change

 
  

2017

  

2016

  

$

  

%

  

2017

  

$

  

%

 

Orders:

                            

Thermal

 $12,133  $7,316  $4,817   66% $8,775  $3,358   38%

EMS

  5,500   3,966   1,534   39%  5,817   (317)  (5)%
  $17,633  $11,282  $6,351   56% $14,592  $3,041   21%
                             

ATE market

 $8,915  $7,008  $1,907   27% $8,689  $226   3%

Non-ATE market

  8,718   4,274   4,444   104%  5,903   2,815   48%
  $17,633  $11,282  $6,351   56% $14,592  $3,041   21%

 

 

Nine
Months Ended
September 30,

  

Change

              

Three
Months Ended
March 31,

  

Change

  

Three
Months

Ended
December 31,

  

Change

 
 

2017

  

2016

  

$

  

%

              

2021

  

2020

  

$

  

%

  

2020

  

$

  

%

 

Orders:

                                                        

Thermal

 $28,168  $20,618  $7,550   37%             $14,746  $10,499  $4,247   40

%

 $11,065  $3,681   33

%

EMS

  19,089   13,101   5,988   46%              10,484   3,277   7,207   220

%

  6,554   3,930   60

%

 $47,257  $33,719  $13,538   40%             $25,230  $13,776  $11,454   83

%

 $17,619  $7,611   43

%

                                                        

ATE market

 $29,163  $23,072  $6,091   26%            

Non-ATE market

  18,094   10,647   7.447   70%            

Semi Market

 $17,174  $6,692  $10,482   157

%

 $11,129  $6,045   54

%

Multimarket

  8,056   7,084   972   14

%

  6,490   1,566   24

%

 $47,257  $33,719  $13,538   40%             $25,230  $13,776  $11,454   83

%

 $17,619  $7,611   43

%

 

Total consolidated orders for the three months ended September 30, 2017March 31, 2021 were $17.6$25.2 million compared to $11.3$13.8 million for the same period in 20162020 and $14.6$17.6 million for the three months ended June 30, 2017. During the three months ended September 30, 2017, the orders of our Thermal segment included $6.4 million of orders attributable to Ambrell, which we acquired on May 24, 2017, as previously discussed. Of the orders attributable to Ambrell, $334,000 wereDecember 31, 2020. Orders from customers in the ATE market and the balance were from non-ATE market customers. When adjusted to eliminate the impact of the orders attributable to Ambrell, our consolidated orders would have decreased $63,000, or 1%, as compared to the same period in 2016, and $1.0 million, or 9%, as compared to the three months ended June 30, 2017. These reductions primarily represent a decrease in orders from our non-ATE market customers in the telecommunications market and were partially offset by continued strong demand from our customers in the ATE market.

- 21 -

inTEST CORPORATION

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Total consolidated orders for the nine months ended September 30, 2017 were $47.3 million compared to $33.7 million for the same period in 2016. When adjusted to eliminate the impact of orders attributable to Ambrell, our consolidated orders for the nine months ended September 30, 2017 would have increased $4.8 million, or 14%, as compared to the same period in 2016. The increase was attributable to our customers in the ATE market. This higher level of demand is being driven, in part, by the increasing number of ICs utilized in the automotive industry and the need to test those ICs. In addition, demand for ATE is also being driven by products which enable the Internet of Things (IoT) and the increasing number of ICs in consumer electronics and industrial applications. The increase from customers in the ATE market was partially offset by a decrease in non-ATE market demand, primarily from customers in the defense/aerospace market.

When adjusted to eliminate the orders attributable to Ambrell, orders from customers in non-ATE marketsMultimarket for the three months ended September 30, 2017March 31, 2021 were $2.6$8.1 million, or 24%32% of total consolidated orders, compared to $4.3$7.1 million, or 38%51% of total consolidated orders for the same period in 20162020 and $3.7$6.5 million or 30%37% of total consolidated orders for the three months ended June 30, 2017. When adjusted to eliminateDecember 31, 2020.

We believe that the increases in our consolidated orders attributable to Ambrell, orders from customers in non-ATE markets forduring the ninethree months ended September 30, 2017, were $9.8 million, or 25% of total consolidated orders asMarch 31, 2021 compared to $10.6 million, or 32% of total consolidated orders for the same period in 2016. As previously mentioned,2020 and to the decreasethree months ended December 31, 2020 primarily reflect the end of the downturn in the Semi Market, where approximately half of our business is derived. This downturn began in the first quarter of 2019. We believe that the significant level of increase in orders from the Semi Market for these same time periods also reflects the impact of the interruption of the normal recovery in the Semi Market cycle that was caused by the onset of COVID-19 in the first half of 2020, as well as increased demand wasfor semiconductors, generally, both of which we believe are driving the current shortage in the global supply of semiconductors (which are also referred to as “integrated circuits” or “ICs”). To a lesser extent, we also experienced an increase in orders from Multimarket, primarily from customers in the telecommunications and defense/aerospace markets. The level of our orders in these non-ATE markets has varied in the past, and we expect it will vary significantly in the future as we build our presence in these markets and establish new markets for our products.

industrial market.

At September 30, 2017,March 31, 2021, our backlog of unfilled orders for all products was approximately $11.3$17.1 million compared with approximately $6.1$8.1 million at September 30, 2016March 31, 2020 and $11.1$11.5 million at June 30, 2017. At September 30, 2017, our backlog included $5.9 million attributable to Ambrell.December 31, 2020. Our backlog includes customer orders which we have accepted, substantially all of which we expect to deliver in 2017.2021. While backlog is calculated on the basis of firm purchase orders, a customer may cancel an order or accelerate or postpone currently scheduled delivery dates. Our backlog may be affected by the tendency of customers to rely on short lead times available from suppliers, including us, in periods of depressed demand. In periods of increased demand, there is a tendency towards longer lead times that has the effect of increasing backlog. As a result, our backlog at a particular date is not necessarily indicative of sales for any future period.

Net Revenues

The following table sets forth, for the periods indicated, a breakdown of the net revenues by productoperating segment and market (in thousands).

 

  

Three
Months Ended

September 30,

  

Change

  

Three
Months Ended

June 30,

  

Change

 
  

2017

  

2016

  

$

  

%

  

2017

  

$

  

%

 

Net revenues:

                            

Thermal

 $11,470  $6,641  $4,829   73% $9,194  $2,276   25%

EMS

  5,882   4,182   1,700   41%  6,694   (812)  (12)%
  $17,352  $10,823  $6,529   60% $15,888  $1,464   9%
                             

ATE market

 $9,162  $8,039  $1,123   14% $10,155  $(993)  (10)%

Non-ATE market

  8,190   2,784   5,406   194%  5,733   2,457   43%
  $17,352  $10,823  $6,529   60% $15,888  $1,464   9%

- 22 -

inTEST CORPORATION

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

 

Nine
Months Ended
September 30,

  

Change

  

Three
Months Ended
March 31,

  

Change

  

Three
Months

Ended
December 31,

  

Change

 
 

2017

  

2016

   $  

%

  

2021

  

2020

  

$

  

%

  

2020

  

$

  

%

 

Net revenues:

                                            

Thermal

 $28,440  $17,429  $11,011   63% $11,055  $9,334  $1,721   18

%

 $10,675  $380   4

%

EMS

  18,980   12,526   6,454   52%  8,501   1,896   6,605   348

%

  4,200   4,301   102

%

 $47,420  $29,955  $17,465   58% $19,556  $11,230  $8,326   74

%

 $14,875  $4,681   31

%

                                            

ATE market

 $29,756  $22,068  $7,688   35%

Non-ATE market

  17,664   7,887   9,777   124%

Semi Market

 $13,320  $5,011  $8,309   166

%

 $7,614  $5,706   75

%

Multimarket

  6,236   6,219   17   -

%

  7,261   (1,025

)

  (14

)%

 $47,420  $29,955  $17,465   58% $19,556  $11,230  $8,326   74

%

 $14,875  $4,681   31

%

 

Total consolidated net revenues for the three months ended September 30, 2017March 31, 2021 were $17.4$19.6 million compared to $10.8$11.2 million for the same period in 20162020 and $15.9$14.9 million for the three months ended June 30, 2017. DuringDecember 31, 2020. We believe the increase in our consolidated net revenues compared to the same period in 2020 and the three months ended September 30, 2017, we recorded $4.9 millionDecember 31, 2020 primarily reflects the aforementioned increase in netdemand from the Semi Market.

-24-

Net revenues attributable to Ambrell, $91,000 of which were from customers in Multimarket for the ATE market and the balancethree months ended March 31, 2021 were $6.2 million, or 32% of which were from non-ATE market customers. Totaltotal consolidated net revenues, compared to $6.2 million, or 55% of total consolidated net revenues for the first nine months of 2017 were $47.4 million compared to $30.0 million for the same period in 2016. During the nine months ended September 30, 2017, we recorded $6.92020 and $7.3 million in net revenues attributable to Ambrell, $122,000or 49% of which were from customers in the ATE market and the balance of which were from non-ATE market customers.

When adjusted to eliminate the impact of the net revenues attributable to Ambrell, the increase in ourtotal consolidated net revenues for the three and nine months ended September 30, 2017, asDecember 31, 2020. The reduced net revenues in Multimarket for the first quarter of 2021 compared to the same periodsfourth quarter of 2020 primarily reflect weaker demand from customers in 2016, primarily reflects strengtheningthe industrial market and, to a lesser extent, customers in demand within the ATE market. When adjusted to eliminate the impact of the net revenues attributable to Ambrell, as a percent of our total consolidated net revenues,defense/aerospace and medical markets. These declines were partially offset by an increase in net revenues from customers in non-ATE marketsthe automotive market. Net revenues from Multimarket customers were 27%relatively flat for both the three and nine months ended September 30, 2017first quarter of 2021 compared to 26%the same period in each2020. Increases from the automotive market were offset by decreases in demand from customers in the industrial and defense/aerospace markets.

COVID-19 Pandemic

Demand from all of the comparable prior periods,markets we serve was significantly affected by COVID-19 during the first half of 2020. The impact of COVID-19 on demand from the Semi Market was intensified during the first half of 2020 because our business operations were also being negatively affected by a global downturn in the Semi Market at that time. The Semi Market, from which approximately half of our orders and 27%net revenues are derived, entered a cyclical downturn in the beginning of 2019. During the first quarter of 2020, before the spread of COVID-19, we had started to see indications that the downturn was coming to an end. These indications included increased quoting activity and order levels for the three months ended June 30, 2017.

Product/Customer Mix

Bothfirst quarter of 2020 compared to the fourth quarter of 2019. However, we believe COVID-19 delayed the recovery in the Semi Market as the increase in activity leveled off during late March 2020. Although we saw slightly increased order rates from our product segments eachcustomers in the Semi Market during the second and third quarters of 2020, it was not until the fourth quarter of 2020 that we saw a significant increase in our orders from the Semi Market, which we believe indicates that we have multiplenow entered the next cyclical upturn. During the fourth quarter of 2020, our orders from the Semi Market increased 53% sequentially and were 141% higher than in the fourth quarter of 2019, the low point of the prior cyclical downturn for the products that we design, manufacturesell. This trend in our orders from the Semi Market continued in the first quarter of 2021 with a further 54% sequential increase from the level in the fourth quarter of 2020. We believe the level of increase in our orders and net revenues from the Semi Market during the fourth quarter of 2020 and the first quarter of 2021 reflects a combination of increased demand in the market resulting from the interruption of the normal recovery in the Semi Market cycle caused by the onset of COVID-19 in the first half of 2020, as well as increased demand for semiconductors, generally. We believe this increase in demand is being driven both by changing technology as well as increased use of technology across all aspects of daily life, such as in devices that facilitate remote work and education, smart technology used in homes and businesses, the increase in the number of ICs used in the automotive industry and changes occurring in the telecommunications and mobility markets.

As of the date of this filing, all of our operations continue to be deemed “critical and essential business operations” under the various governmental COVID-19 mandates, which has allowed us to continue to operate our business with certain modifications. These modifications include a significant number of our employees working remotely. Such employees have been provided with the tools and technology necessary to do so. Additionally, we have implemented workplace safeguards designed to protect the health and well-being of our employees. Employees who remain in our facilities are following WHO and CDC recommended safety practices, as well as state and local directives. We have had occasions where one or more employees have contracted COVID-19 and entered our facilities while infected. To date, we have managed these occurrences with minimal disruption to our customers. Duebusiness while protecting other employees, but there can be no assurances that we can avoid similar occurrences in the future or, that in such cases, we can avoid significant disruption of our operations.

The aftermarket service and support that we provide to our customers has been, and we expect may continue to be, adversely impacted by COVID-19. Specifically, the travel restrictions that remain in place, coupled with limitations on visitors into customer facilities, have resulted in the reduction or suspension of in-person service and support activities. The net revenues associated with these aftermarket service and support activities typically range from 8% to 10% of our consolidated net revenues. Although these net revenues returned to a numbermore typical range during the second half of factors,2020, they declined again in the first quarter of 2021. If the spread of COVID-19 or variations of the virus worsen, these revenues may continue to be reduced in future periods.

While the negative impact of COVID-19 on our products have varying levelsbusiness was reduced significantly in the second half of gross margin. The mix2020 and the first quarter of products we sell2021, the spread of the virus or variants of the virus could worsen and one or more of our significant customers or suppliers could be impacted, or significant additional governmental regulations and restrictions could be imposed, thus negatively impacting our business in any period is ultimately determined by our customers' needs. Therefore, the mix of products sold in any given period can change significantly from the prior period.future. As a result of our current level of working capital as well as the availability of our revolving credit facility, which is discussed in Note 9 to our consolidated gross margin can be significantly impactedfinancial statements in any given period by a changethis Report, we currently expect to have sufficient liquidity to operate our business throughout 2021. Our revolving credit facility, which had no outstanding balance, was set to mature on April 9, 2021. As discussed in the mix of products soldNote 14 to our consolidated financial statements in that period.

We sell most of our products to semiconductor manufacturersthis Report, we modified this facility on April 10, 2021 and third-party test and assembly houses (end user sales) and to ATE manufacturers (OEM sales) who ultimately resell our equipment with theirs to both semiconductor manufacturers and third-party test and assembly houses. Our Thermal segment also sells into a variety of other markets, including the automotive, consumer electronics, defense/aerospace, energy, industrial and telecommunications markets, and,extended it as a result of the acquisition of Ambrell, the consumer products packaging, fiber optics and other markets. The mix of customers during any given period will affect our gross margin due to differing sales discounts and commissions. For the three months ended September 30, 2017 and 2016, our OEM sales as a percentage of net revenues were 2% and 3%, respectively. For the nine months ended September 30, 2017 and 2016, our OEM sales as a percentage of net revenues were 6% and 5%, respectively.

OEM sales generally have a lower gross margin than end user sales, as OEM sales historically have had a more significant discount. Our current net operating margins on most OEM sales, however, are only slightly less than margins on end user sales because of the payment of third party sales commissions on most end user sales. We have also continued to experience demands from our OEM customers' supply chain managers to reduce our sales prices to them. If we cannot further reduce our manufacturing and operating costs, these pricing pressures will negatively affect our gross and operating margins.
modified through April 9, 2024.

 

- 23 -
-25-

 

inTEST CORPORATIONResults of Operations

 

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations

The results of operations for our two productoperating segments are generally affected by the same factors described in the Overview section above.and COVID-19 Pandemic section. Separate discussions and analyses for each product segment would be repetitive. The discussion and analysis that follows, therefore, is presented on a consolidated basis and includes discussion of factors unique to each product segment where significant to an understanding of that segment.

Three MonthsMonths Ended September 30, 2017March 31, 2021 Compared to Three MonthsMonths Ended September 30, 2016March 31, 2020

Net Revenues. Net revenues were $17.4$19.6 million for the three months ended September 30, 2017March 31, 2021 compared to $10.8$11.2 million for the same period in 2016,2020, an increase of $6.5$8.3 million, or 60%74%. Our net revenues for the three months ended September 30, 2017 included $4.9 million of net revenues attributable to Ambrell. We believe the significant increase in our net revenues during the thirdfirst quarter of 20172021 primarily reflects the factorscurrent cyclical upturn in the Semi Market as previously discussed in the Overview.Overview and COVID-19 Pandemic section.

Gross Margin. Our consolidated gross margin was 51%49% of net revenues for the three months ended September 30, 2017 asMarch 31, 2021 compared to 52%43% of net revenues for the same period in 2016.2020. The decreaseincrease in our gross margin as a percentage of net revenues primarily reflects an increase in our fixed operating costs. Of the $1.1 million increase in these costs, $913,000 represents the fixed operating costs attributable to Ambrell. The remaining $166,000 increasea decrease in our fixed operating costs primarily reflectsas a percentage of net revenues. Although our fixed operating costs were relatively unchanged in absolute dollar terms, they declined from 22% of net revenues in the first quarter of 2020 to 13% of net revenues in the first quarter of 2021. This is a result of these costs being more fully absorbed by the higher salarynet revenues levels in the first three months of 2021. Our accruals for excess and benefits expense forobsolete inventory declined in absolute dollar terms by $131,000, or 77%, and as a percentage of net revenues, from 2% in the first quarter of 2020 to less than 1% in the first quarter of 2021. The decreases in our Thermal segment.fixed operating costs and excess and obsolete inventory charges were partially offset by an increase in our component material costs as a percentage of net revenues, reflecting changes in the mix of products sold.

Selling Expense. Selling expense was $2.3$2.4 million for the three months ended September 30, 2017March 31, 2021 compared to $1.4$2.1 million for the same period in 2016,2020, an increase of $928,000,$351,000, or 67%17%. Our expenseThe increase primarily reflects higher levels of commissions in our EMS segment as a result of the higher net revenue levels achieved for the three months ended September 30, 2017 included $850,000March 31, 2021 compared to the same period in 2020. This increase was partially offset by a reduction in travel costs for the three months ended March 31, 2021 compared to the same period in 2020. Our sales personnel have not yet returned to the level of selling costs attributabletravel that was typical prior to Ambrell. The remaining increasethe onset of $78,000 primarily reflects an increase in salary and benefits expense for our Thermal segment.COVID-19.

Engineering and Product Development Expense. Engineering and product development expense was $1.1relatively unchanged at $1.3 million for both the three months ended September 30, 2017 compared to $905,000 forMarch 31, 2021 and 2020. There were no significant changes in any of the same period in 2016, an increasecomponents of $234,000, or 26%. Engineering expense attributable to Ambrell in the third quarter of 2017 was $269,000. When adjusted to eliminate this amount, engineering expense would have decreased $35,000, or 4%, for the third quarter of 2017 as compared to same period in 2016. This decrease primarily reflects reduced spending on legal matters related to our intellectual property which was partially offset by an increase in the cost of materials used in newand product development for our Thermal segment.expense.

General and Administrative Expense. General and administrative expense was $3.1$3.2 million for the three months ended September 30, 2017March 31, 2021 compared to $1.6$2.9 million for the same period in 2016,2020, an increase of $1.6 million,$285,000, or 100%10%. Our expenses for the third quarterThe increase primarily reflects higher levels of 2017 included $31,000 of transaction costs related to the acquisition of Ambrell on May 24, 2017,profit-based bonus accruals and $1.3 million of general and administrative expense attributable to Ambrell. Ambrell’s general and administrative expense included $560,000 of amortization of intangible assets. When adjusted to eliminate these items, general and administrative expense would have increased $258,000 or 17%, primarily reflecting an increase in accruals for profit related bonuses, higherthe value of stock-based compensation awards granted to our senior management and Board of Directors. These increases were partially offset by a reduction in salary and benefits expense, including deferred compensation expense relatedreflecting headcount reductions. The reduction in headcount was primarily in our Thermal segment and, to stock-based awards. To a lesser extent, there wasin our corporate staff. We also an increase inrecorded a lower level of fees paid tofor third party professionals who assist us in a variety of compliance related matters during the first quarter of 2021 compared to the same period in 2020.

Restructuring and an increase in travel cost.

Contingent Consideration Liability.Other Charges. DuringFor the three months ended September 30, 2017,March 31, 2021, we recorded a reduction of $549,000$55,000 in restructuring and other charges related to the fair valueconsolidation of our liability for contingent consideration. This liability is a result ofEMS manufacturing operations. During the same period in 2020, we recorded $8,000 in restructuring and other charges related to headcount reductions in our acquisition of Ambrell in May 2017 and is discussed further in Notes 3 and 4 to our consolidated financial statements. The reduction in the fair value is primarily a result of a reduction in the projected adjusted EBITDA of Ambrell for the year ending December 31, 2017.

Corporate staff.

Income Tax Expense.Expense (Benefit). For the three months ended September 30, 2017,March 31, 2021, we recorded income tax expense of $823,000$366,000 compared to $631,000an income tax benefit of $250,000 for the same period in 2016.2020. Our effective tax rate was 29%14% for the three months ended September 30, 2017March 31, 2021 compared to 37%18% for the same period in 2016.2020. On a quarterly basis, we record income tax expense or benefit based on the expected annualized effective tax rate for the various taxing jurisdictions in which we operate our businesses. The decrease in our effective tax rate reflects recording the aforementioned reduction of $549,000 in our liability for contingent consideration which is not taxable.

- 24 -

inTEST CORPORATION

 

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Nine Months Ended September 30, 2017 Compared to Nine Months Ended September 30, 2016

Net Revenues. Net revenues were $47.4 million for the nine months ended September 30, 2017 compared to $30.0 million for the same period in 2016, an increase of $17.4 million, or 58%. Our net revenues for the nine months ended September 30, 2017 included $6.9 million of net revenues attributable to Ambrell. We believe the increase in our net revenues during the first nine months of 2017 primarily reflects the factors previously discussed in the Overview section above.

Gross Margin. Our consolidated gross margin was 53% for the nine months ended September 30, 2017 as compared to 50% for the same period in 2016. Although our fixed operating costs increased $1.8 million in absolute dollar terms, they were more fully absorbed by the higher net revenue levels. Of the $1.8 million increase in the absolute dollar value of these costs, $1.3 million represents the fixed operating costs attributable to Ambrell. The remaining $506,000 increase in our fixed operating costs primarily reflects higher salary and benefits expense for our Thermal segment as a result of an increased use of temporary labor for operations support due to the increased order and shipment activity. To a lesser extent, the increase in gross margin as a percentage of net revenues also reflects a reduction in our component material costs as a percentage of net revenues as a result of changes in product and customer mix.

Selling Expense. Selling expense was $5.9 million for the nine months ended September 30, 2017 compared to $4.2 million for the same period in 2016, an increase of $1.7 million, or 40%. Our expense for the nine months ended September 30, 2017 included $1.2 million of selling costs attributable to Ambrell. The remaining increase of $494,000 primarily reflects higher levels of commission expense reflecting the higher net revenues, and to a lesser extent, an increase in travel costs and salary and benefits expense for our Thermal segment.

Engineering and Product Development Expense. Engineering and product development expense was $3.1 million for the nine months ended September 30, 2017 compared to $2.9 million for the same period in 2016, an increase of $178,000, or 6%. Our expense for the nine months ended September 30, 2017 included $351,000 of engineering costs attributable to Ambrell. When adjusted to eliminate this amount, engineering expense would have decreased $173,000, or 6%, for the first nine months of 2017 as compared to same period in 2016. This decrease primarily reflects reduced spending on legal matters related to our intellectual property and lower salary and benefits expense for our EMS product segment.

General and Administrative Expense. General and administrative expense was $8.4 million for the nine months ended September 30, 2017 compared to $5.4 million for the same period in 2016, an increase of $3.1 million, or 57%. Our expenses for the first nine months of 2017 included $880,000 of transaction costs related to the acquisition of Ambrell on May 24, 2017, and $1.8 million of general and administrative expense attributable to Ambrell. Ambrell’s general and administrative expense included $757,000 of amortization of intangible assets. Our expenses for the first nine months of 2016 included $479,000 of transaction costs related to an acquisition that did not close. When adjusted to eliminate these items, general and administrative expense would have increased $850,000 or 17%, primarily reflecting higher salary and benefits expense and an increase in accruals for profit-related bonuses. To a lesser extent there was also an increase in travel costs and professional fees.

Contingent Consideration Liability. During the nine months ended September 30, 2017, we recorded a reduction of $549,000 in the fair value of our liability for contingent consideration. This liability is a result of our acquisition of Ambrell in May 2017 and is discussed further in Notes 3 and 4 to our consolidated financial statements. The reduction in the fair value is primarily a result of a reduction in the projected adjusted EBITDA of Ambrell for the year ending December 31, 2017.

Income Tax Expense. For the nine months ended September 30, 2017, we recorded income tax expense of $2.8 million compared to $937,000 for the same period in 2016. Our effective tax rate was 34% for the nine months ended September 30, 2017 compared to 36% for the same period in 2016. On a quarterly basis, we record income tax expense or benefit based on the expected annualized effective tax rate for the various taxing jurisdictions in which we operate our businesses. The decrease in our effective tax rate reflects the aforementioned adjustment to our liability for contingent consideration.

Liquidity and Capital Resources

As discussed more fully in the Overview, our business and results of operations are substantially dependent upon the demand for ATE by semiconductor manufacturers and companies that specialize in the testing of ICs. The cyclical and volatile nature of demand for ATE makes estimates of future revenues, results of operations and net cash flows difficult.

 

- 25 -
-26-

inTEST CORPORATION

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

 

Our primary historical source of liquidity and capital resources has been cash flow generated by our operations, and we manage our businesses to maximize operating cash flows as our primary source of liquidity. We use cash to fund growth in our operating assets, for new product research and development, for acquisitions and for stock repurchases.

 

Liquidity

Our cash and cash equivalents and working capital were as follows:follows (in thousands):

 

 

September 30, 2017

  

December 31, 2016

  

March 31,
2021

  

December 31,
2020

 

Cash and cash equivalents

 $11,499  $28,611  $10,195  $10,277 

Working capital

 $19,604  $32,950  $21,285  $18,108 

 

As of September 30, 2017, $2.7March 31, 2021, $3.4 million, or 33%, of our cash and cash equivalents was held by our foreign subsidiaries. When these funds are needed for our operations in the U.S., we may be required to accrue and pay U.S. taxes if we repatriate certain of these funds.

We currently expect our cash and cash equivalents, in combination with the borrowing capacity available under our revolving credit facility and projected futurethe anticipated net cash flowto be provided by our operations in the next twelve months to be sufficient to support our short termshort-term working capital requirements the post-acquisition integration of Ambrell, the potential contingent consideration payments for Ambrell and other corporate requirements. Our revolving credit facility is discussed in Notes 1, 9 and 14 to our consolidated financial statements in this Report.

Our material short-term cash requirements include payments due under our various lease agreements, recurring payroll and benefits obligations to our employees and purchase commitments for materials that we use in the products we sell. We estimate that our minimum short-term working capital requirements currently range between $5.0 million and $7.0 million. We also anticipate making investments in our business in the next twelve months including hiring of additional staff, updates to our website and other systems and investments related to our geographic and market expansion efforts. We expect our current cash and cash equivalents, in combination with the borrowing capacity available under our revolving credit facility and the anticipated net cash to be provided by our operations to be sufficient to support these additional investments as well as our current short-term cash requirements. However, should the impact of COVID-19 on our operations, including the disruption to our business that would be caused by any unanticipated facility closures or significantly reduced demand from our customers, be more significant than we currently expect, we may need additional financial resources, including additional debt or equity financings in the long-term. There can be no assurance that any such debt or equity financings would be available on favorable terms or rates or at all.

Our current growth strategy includes pursuing acquisition opportunities for complementary businesses, technologies or products. We currently anticipate that any long-term cash requirements related to consummate a significantour acquisition if the consideration in such a transactionstrategy would require us to utilize a substantial portion of, or an amount equal tobe funded all or in excess of, our available cash. Wepart through obtaining additional third-party debt or issuing equity. If we were to obtain additional third-party debt, we do not currently haveknow at what rates or on what terms any credit facilities under which we can borrow to help fund our working capital or other requirements.

such debt would be available.

Cash Flows

Operating Activities.
Net cash provided by operations forFor the ninethree months ended September 30, 2017 was $5.2 million. During the nine months ended September 30, 2017,March 31, 2021, we recorded net earnings of $5.5 million which included$2.2 million. Net cash used in operations during this period was $337,000. During the three months ended March 31, 2021, we had non-cash charges of $1.3 million$740,000 for depreciation and amortization a $549,000 reduction inwhich included $280,000 of amortization related to our ROU assets. During the fair value of our contingent consideration liability, $292,000three months ended March 31, 2021, we also recorded $269,000 for amortization of deferred compensation expense related to stock-based awards and $161,000 as a provision for excess and obsolete inventory. Approximately $757,000 of our amortization expense was related toawards. Accounts receivable increased $5.1 million during the intangible assets acquired as part ofthree months ended March 31, 2021, reflecting the acquisition of Ambrellsignificant increase in May 2017, which is discussed furthernet revenues in the Overviewfirst quarter, while inventories and Note 3 to our consolidated financial statements. When adjusted to eliminateaccounts payable increased $783,000 and $1.2 million, respectively, also reflecting the assets and liabilities purchasedincrease in the acquisition of Ambrell, accounts receivable and inventoriesbusiness levels. Customer deposits increased $1.1 million and $581,000, respectively,$799,000 during the ninethree months ended September 30, 2017 compared to the levels at the end of 2016. These increasesMarch 31, 2021, primarily reflect the increased business activity during the first nine months of 2017 as compared to the fourth quarter of 2016. During the nine month months ended September 30, 2017, domestic and foreign income taxes payable increased $472,000 as a result of higher levels of taxable income during the first nine months of 2017.in our Thermal segment.

Investing Activities. During the ninethree months ended September 30, 2017, we completed the acquisition of Ambrell for $22.0 million, net of cash acquired, as discussed in further detail in the Overview and Note 3 to our consolidated financial statements. During the nine months ended September 30, 2017,March 31, 2021, purchases of property and equipment were $435,000. We currently plan to spend approximately $1.5 million to $2.0 million on$388,000, primarily reflecting leasehold improvements for a newto our facility for Ambrell in Rochester,Mt. Laurel, New York. We expect to spend these funds during the fourth quarter of 2017 and the first quarter of 2018 and expect to take occupancy on May 1, 2018.Jersey which were funded using our working capital. We have no other significant commitments for capital expenditures for the balance of 2017;2021; however, depending upon changes in market demand or manufacturing and sales strategies, we may make such purchases or investments as we deem necessary and appropriate.

These additional cash requirements would be funded by our cash and cash equivalents, anticipated net cash to be provided by operations and our revolving credit facility.

Financing Activities.Activities. During the ninethree months ended September 30, 2017,March 31, 2021, we utilized $62,000received $717,000 as a result of the exercise of options to repurchase 13,883acquire 99,740 shares of our common stockstock. These options were issued to certain current and former employees under the 2015 Repurchase Plan.our stock-based compensation plans which are discussed in Note 10 to our consolidated financial statements in this Report.

-27-

New or Recently Adopted Accounting Standards

See the Notes to our consolidated financial statements for information concerning the implementation and impact of new or recently adopted accounting standards.

- 26 -

inTEST CORPORATION

 

Item 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Critical Accounting PoliciesEstimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of AmericaGAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to inventories, long-lived assets, goodwill, identifiable intangibles, contingent consideration liabilities and deferred income tax valuation allowances. We base our estimates on historical experience and on appropriate and customary assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Some of these accounting estimates and assumptions are particularly sensitive because of their significance to our consolidated financial statements and because of the possibility that future events affecting them may differ markedly from what had been assumed when the financial statements were prepared. As of September 30, 2017,March 31, 2021, there have been no significant changes to the accounting policiesestimates that we have deemed critical. These policiescritical other than the change in accounting estimate that is discussed in Note 2 to our consolidated financial statements in this Report. Our critical accounting estimates are more fully described in our 20162020 Form 10-K.

Off -Balance Sheet Arrangements

There were no off-balance sheet arrangements during the ninethree months ended September 30, 2017March 31, 2021 that have or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to our interests.


Item 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

This disclosure is not required for a smaller reporting company.


Item 4.CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act").Act. Because there are inherent limitations in all control systems, a control system, no matter how well conceived and operated, can provide only reasonable, as opposed to absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Our management, including ourthe Chief Executive Officer ("CEO"(“CEO”) and Chief Financial Officer ("CFO"(“CFO”), does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all error and all fraud. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Accordingly, our management has designed the disclosure controls and procedures to provide reasonable assurance that the objectives of the control system were met.

CEO/CFO Conclusions about the Effectiveness of the Disclosure Controls and Procedures. As required by Rule 13a-15(b), of the Exchange Act, inTEST management, including our CEO and CFO, conducted an evaluation as of the end of the period covered by this report,Report, of the effectiveness of our disclosure controls and procedures.procedures, including the impact of COVID-19. Based on that evaluation, our CEO and CFO concluded that, as of the end of the period covered by this report,Report, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

ThereDuring the period covered by this Report, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 We will continue monitoring and assessing any impacts from COVID-19 on our internal controls.

 

- 27 -
-28-

 

PART II.OTHER INFORMATION

Item 1.Legal Proceedings

Legal Proceedings

 

From time to time we may be a party to legal proceedings occurring in the ordinary course of business. We are not currently involved in any material legal proceedings.

Item 1A. Risk Factors

Risk Factors

 

Information regarding the primary risks and uncertainties that could materially and adversely affect our future performance or could cause actual results to differ materially from those expressed or implied in our forward-looking statements, appears in Part I, Item 1A - "Risk Factors" of our 20162020 Form 10-K filed with the Securities and Exchange Commission on March 27, 2017.23, 2021. There have been no changes from the risk factors set forth in our 2020 Form 10-K.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

 

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

On October 27, 2015, our Board of Directors authorized the repurchase of up to $5.0 million of our common stock from time to time on the open market, in compliance with Rule 10b-18 under the Exchange Act, or in privately negotiated transactions (the "2015 Repurchase Plan"). Repurchases may also be made under trading plans entered into with RW Baird & Co. (each a "10b5-1 Plan"), which permit shares to be repurchased when we might otherwise be precluded from doing so under insider trading laws. The 2015 Repurchase Plan does not obligate us to repurchase any particular amount of common stock and may be suspended or discontinued at any time without prior notice. The 2015 Repurchase Plan is funded using our operating cash flow or available cash. The timing, price and amount of any shares repurchased under the 2015 Repurchase Plan is determined by our management, based on our evaluation of market conditions and other factors. To date, all purchases have been made in accordance with 10b5-1 Plans which provided for purchases to be made so long as the price did not exceed a maximum price. Recently, the price of our shares has exceeded the cap. Management is considering new parameters for future purchases and may enter into a new 10b5-1 Plan at some point under those new parameters. For the three months ended September 30, 2017, there were no shares repurchased. As of September 30, 2017 all of the Company’s 10b5-1 Plans had expired.

Item 3.

Defaults Upon Senior Securities

None.

 

 

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Mine Safety Disclosures

 

Not applicable.

Item 5.Other Information

Other Information

 

None.

 

- 28 -

 

PART II.  OTHER INFORMATION

Item 6.Exhibits

Exhibits

 

10.1

10.12021 Executive Officer Compensation Plan. (1)(*)

10.2

Form of IndemnificationIncentive Stock Option Agreement.(1)(*)

10.3

Form of Non-Qualified Stock Option Agreement. (1)(*)

10.4

Second Amendment to Lease Agreement, dated April 7, 2021, by and between inTEST Corporation and Exeter 804 East Gate 2018, LLC. (2)

10.5

Second Amendment to Loan and Security Agreement, dated April 10, 2021 by inTEST Corporation, Ambrell Corporation, inTEST Silicon Valley Corporation, inTEST EMS, LLC, Temptronic Corporation and M&T Bank. (3)

10.6

Amended and Restated Revolver Note, dated April 10, 2021. (3)

31.1

Certification of Chief Executive Officer pursuant to Rule 13a-14(a).

31.2

Certification of Chief Financial Officer pursuant to Rule 13a-14(a).

32.1

Certification of Chief Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of Chief Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

99.1

Press Release of inTEST Corporation, issued October 23, 2017.(2)

101.INS

XBRL Taxonomy Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

(1)

Previously filed by the Company as an exhibit to the Company’sCompany’s Current Report on Form 8-K dated October 2, 2017,March 10, 2021, File No. 001-36117, filed October 6, 2017,March 16, 2021, and incorporated herein by reference.

 

(2)

Previously filed by the Company as an exhibit to the Company’sCompany’s Current Report on Form 8-K dated October 20, 2017,April 7, 2021, File No. 001-36117, filed October 23, 2017,April 13, 2021, and incorporated herein by reference.

(3)

Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated April 10, 2021, File No. 001-36117, filed April 14, 2021, and incorporated herein by reference.

*

Indicates a management contract or compensatory plan, contract or arrangement in which directors or executive officers participate.

 

- 29 --29-

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

inTEST Corporation

   
   
   

Date:

November May 13, 202114, 2017

/s/ Robert E. MatthiessenRichard N. Grant, Jr.

Robert E. MatthiessenRichard N. Grant, Jr.
President and Chief Executive Officer

   
   
   

Date:

November May 13, 202114, 2017

/s/ Hugh T. Regan, Jr.

Hugh T. Regan, Jr.
Secretary, Treasurer and Chief Financial Officer

 

-30-